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Executive Summary 
This report reviews the current status of the medicinal plant sector in India, which supports the primary 
health care needs of most of the country's population. Much of the health care sector is informal, especially 
since India has three major systems of traditional medicine. However, many plant products are used for tribal 
and folk medicinal practices which have not been properly studied. India therefore is one of the world's most 
medico-culturally diverse countries. Added to this scenario is the practice of Western medicine and past 
efforts to change indigenous medicine: in fact both have benefited from each other since indigenous systems 
introduced drugs to the Western pharmacopoeias while Western medicine helped upgrade a few important raw 
plant products to some degree of standardization. 
The synergies described above led to India becoming an active participant in the global medicinal plant 
market, Although an insignificant supplier of finished products, India may be the world's largest supplier of raw 
materials. This global trade is strongly geared to the needs of importers: hence emphasis on production for the 
trade is often on plants introduced into India. Nonetheless, India exports significant quantities of raw materi- 
als to other Asian countries and some of these exports are associated with traditional medicine. However, 
India's comparative advantage in producing materials for export has not been exploited to the full at all. 
With the exception of a limited number of plant species, the production base relies mainly on materials 
harvested from the wild. Current practices are unsustainable and many studies have emphasized rapid 
depletion of the natural resource base. This problem is further compounded by the inequitable nature of the 
harvesting and marketing of the plants, thereby perpetuating impoverishment for those charged with steward- 
ing and gathering the resource. Evidence points to a limited number of people profiting in dramatic dispropor- 
tion to their inputs. 
Nonetheless, India, known to be a storehouse of biological diversity, has to focus on sustaining the 
resource base of medicinal plants. Efforts to relieve pressure on wild plants through cultivation have made a 
good start but have a long way to go. This is a complex issue by virtue of the sheer numbers of plant species 
and the needs for sustainable propagation, suitable agronomic practices, the selection of superior genotypes 
and linking production to people. 
Constraints exist at all levels especially in relation to the documentation of the sector. The report 
discusses these in relation to the resource base; use of medicinal plants at the local level; marketing chan- 
nels; exports; the domestic drug production sector and coordination efforts and information. Although the 
overall sector is largely informal, it works in practice. However the constraints are likely to have an increasing 
impact, resulting perhaps in a crisis situation. 
It is not a simple matter of supplying missing documentation. There are extremely diverse stakeholders 
spanning the formal sectors of agriculture, forestry, health care and industry (as well as actors outside of 
these formal sectors). Medicinal plants fall into segments of these formal sectors and receive more or less 
attention depending on policy. For instance, they are one of the most valuable components of the non-timber 
forest products sector, being important generators of revenue. 
Most of the available data regarding the formal sectors are in aggregate form and such statistics supply 
little information about how the market actually works; they rely solely on market price as an indicator of value. 
Much more attention therefore needs to be given to the socio-institutional context of the market. 
(xi) 
On the other hand, the government has in place a wide range of organizations with initiatives aimed at 
strengthening various aspects of the sector and coordinating parts of it. These are supplemented by many 
non-governmental initiatives, several supported by outside donors. New government coordination efforts 
would not however be feasible at present due to the currently apparent constraints. 
It is clear that a set of interventions at various levels could lead to the promotion of the sustainable and 
equitable development of the sector and help to avert a crisis. These could pave the way for sharply focused 
strategic planning for the future. The report outlines a number of these interventions. 
(xii) 
Foreword 
According to the World Health Organization, over 80 percent of the world's population relies on traditional 
forms of medicine, largely plant-based, to meet primary health care needs. 
In India, the collection and processing of medicinal plants and plant products contributes at least 35,000,000 
man days each year to the national economy, as a source of both full and part-time employment. Micro- 
studies suggest that a large number of those employed are women. In recognition of the significance of the 
sub-sector, and the fact that it is largely undocumented, the World Bank and the IDRC Medicinal Plants 
Network (IMPN) agreed to produce this state-of-the-art report on the medicinal plants sector in India. 
The report suggests that despite a wealth of resources-biological, human and financial-being available, 
the lack of a coordinated approach, which considers sustainable and equitable development to be short as 
well as long-term goalsfor the sub-sector, has resulted in the simultaneous under-utilization and overexploitation 
of the valuable plant resources. 
It is hoped that the report, will be a step towards achieving such a coordinated effort. In addition to 
identifying information gaps and research priorities, it outlines a set of possible interventions at various levels 
which could lead to the promotion of the sustainable and equitable development of the sub-sector for human 
and environmental benefit. These could pave the way for sharply focused strategic planning in the future. 
We hope th'at the report will be useful to government agencies, development planners, researchers, 
NGOs, and donor agencies, who can work together to make the sector more sustainable and equitable. 
Roger Finan Madhav Karki, Ph.D. 
Regional Director & Program Officer Program Coordinator 
South Asia Regional Office (SARO) Medicinal & Aromatic Plants Program in Asia (MAPPA) 
IDRC, New Delhi, India. SARO/IDRC, New Delhi, India. 
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Introduction 
Medicinal Plants: 
The Global View 
Human beings have been utilizing plants for basic preventive and curative health care since time 
immemorial. Recent estimates suggest that over 9,000 plants have known medicinal applications in various 
cultures and countries, and this is without having conducted comprehensive research amongst several indigenous 
and other communities (Farnsworth and Soejarto 1991). 
Medicinal plants are used at the household level by women taking care of their families, at the village 
level by medicine men or tribal shamans, and by the practitioners of classical traditional systems of medicine 
such as Ayurveda, Chinese medicine, or the Japanese Kampo system. According to the World Health 
Organization, over 80% of the world's population, or 4.3 billion people, rely upon such traditional plant-based 
systems of medicine to provide them with primary health care (Bannerman et. al. 1983). 
Allopathic medicine too owes a tremendous debt to medicinal plants: one in four prescriptions filled in a 
country like the United States are either a synthesized form of or derived from plant materials (Srivastava, et. 
al. 1995). 
Even from the earliest trade data available, it is clear that the global market for medicinal plants has 
always been very large. According to the International Trade Centre, as far back as 1967, the total value of 
imports of starting materials of plant origin for the pharmaceutical and cosmetics industry was of the order of 
USD 52.9 million. From this amount, the total values grew to USD 71.2 million in 1971, and then showed a 
steady annual growth rate of approximately 5-7% through to the mid-i 980s (Atisso 1983). 
To give an example of the extent of trade volumes even at that time, according to one report commis- 
sioned by the World Wide Fund for Nature, the total import in 1980 of vegetable materials used in pharmacy" 
by the European Economic Community was 80,738 tons (Lewington 1992). India was the largest supplier by 
far, with 10,055 tons of plants and 14 tons of vegetable alkaloids and their derivatives. 
However, it is only during the last decade that the real significance of the medicinal plants sector has 
begun to be realized. Interest in natural materials by the dominant economic powers had waned from the late 
1 960s to the early 1 980s as new possibilities in biotechnology and the synthesization of drugs beckoned. But 
by the mid-i 980s, there was a renewed interest in natural materials and approaches to health care, coupled 
with a recognition that technology alone could not solve the pressing health care needs of the world's popula- 
tion (Tempesta and King 1994). 
This new drive for natural and plant-based medicines made itself felt in the market from the mid-i 980s 
onwards. As Table 1.1 illustrates, growth in the market in various regions is now on average 3 to 4 times the 
average growth rates of the national economies in the same regions. Some of these phenomenal rates, in 
some cases nearly 20%, imply that the market is now doubling in size every 4-5 years. 
The participation of various companies in the market also attests to its new strength and importance. By 
1990, some 223 major companies worldwide (of which about half were in the United States) were reportedly 
screening plants for new leads; the figure had been zero in 1980 (Aryal 1993). 
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Also in 1990, more than 2000 companies in Europe alone were marketing herbal medicinals, with 30% 
having a turnover in excess of $20 million- expenditure in the United States on "unconventional, alternative, or 
unorthodox" therapies reached $13.7 billion dollars during the same year (Tewari 1996). The so-called 
Table 1.1 Natural Medicines Market: Regional Growth Rates 1991-98 (in %) 
Region 1991 -92 1993-981 
EU 5 8 
Rest of Europe 8 12 
SE Asia 12 12 
Japan 15 15 
South Asia 15 15 
Source: Grunwald (1994) 
'riutraceuticals" sector--consisting of herbal medicines which are dubbed food or dietary supplements in order 
to pass FDA criteria more easily--is now estimated to be valued at USD27 billion (Anon 1995). 
The use of such alternative medicines has become increasingly popular in the developed world. For 
example, 1 in 3 Americans have at some time used unconventional medical therapies according to a national 
telephone survey published in the New England Journal of Medicine in 1993. In another survey conducted in 
1994, it was found that 60% of doctors had at some time referred patients to practitioners of alternative 
medicine. In response to the overwhelming interest in alternative therapies, many of the prestigious allopathic 
medical institutions have also recognized their importance: an example is the National Institute of Health 
which created the Office of Alternative Medicine in 1991 to provide the public with information on alternative 
treatments and to assess those therapies which have proven successful. (Kolata 1996). 
According to one account, in 1992 significant amounts of at least 74 species of medicinal plants were 
being commercially traded in the global market (Handa 1992). In addition to these major species, hundreds of 
others are bought and sold in lesser quantities across national boundaries, sometimes illegally. 
A comparison of the volumes of traded materials with those of the previous decade also provides dra- 
matic evidence of the market's growth. During the last 3 years, approximately 40,000 tons of plant drug 
materials (valued at DM 160 million) were imported into Germany, annually (Lange 1996), implying that one 
country's imports in the mid 1 990s equalled half the number of plants imported by the entire continent in the 
mid 1980s. 
Considering the Role for India 
The global context briefly sketched above suggests several tremendous opportunities for India, a coun- 
try unrivaled in terms of diversity of medical systems and practices, in addition to being a major storehouse of 
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biological diversity, with 2 of the 14 megabiodiversity areas of the world located within its borders. The global 
market would appear to be more receptive than ever to the mounting of a concentrated Indian effort at supply- 
ing it with medical materials and know-how. Such an effort would also appearto be increasingly remunerative 
for the country. India is of course already an active participant in the global medicinal plants market having 
been for some time the world's largest supplier of raw materials (though an insignificant supplier of finished 
products) (Patnaik 1994). Of the 74 species accounted for in one of the studies mentioned above, India was 
known to be exporting 22 and importing 8 (Handa 1992), while the German study quoted earlier, which is now 
underway, has found India to be Germany's largest trading partner by far (Lange 1996). Moreover, medicinal 
plants are one of the most important components of the non-wood forest products sector which supplies over 
80% of India's net forest annual export earnings (FAQ 1995, Jam 1996). 
Despite these promising indications, however, it is unclear whether India is truly exploiting her compara- 
tive advantage in the medicinal plants sector and tapping the full potential of an expanding consumer base. In 
addition, several concerns arise in relation to the current consequences of participation in the market, with 
regard to the sustainability and equitability of prevailing practices in the sector. 
Although only micro-studies are currently available in this regard, most of these indicate that current 
practices are both unsustainable, as hey rapidly deplete the natural supplies of the country's plant base, and 
inequitable, perpetuating impoverishment for those charged with stewarding and harvesting the resource, 
while a few profit in dramatic disproportion to their inputs. Negative impacts on local primary health care, as 
plants become diverted to national and international markets, have also been cited in some cases. To add to 
all of these negative aspects, the market in India has been shown to be highly inefficient and imperfect. 
The need of the hour, then, is to replan India's participation in the expanding global market, in light of the 
interests of all the stakeholders who are affected and who play a role in this sector. There is a need to collate 
all the available information regarding medicinal plants development in the country in order to obtain a compre- 
hensive overview which will provide the necessary insight for coordinated and effective action. Such an 
overview could form the basis of a renewed development of India's medicinal plants sector, and a strategic 
exploitation of her comparative advantage in the global market on a sustainable and equitable basis. 
s nd Object!ves o the Revew 
It was with the intention of providing such a comprehensive overview that the International Development 
Research Centre and the World Bank's Department of Agriculture and Natural Resources commissioned the 
authors to conduct a state-of-the-art review of the medicinal plants sector in India. 
Medicinal plants, of course, do not presently constitute a sector as typically defined in international 
development discourse; generally they have been defined as a forestry sub-sector, or less often, as a sub- 
sector in health care. However, this review takes up medicinal plants as an independent sector for two 
reasons: 1) to emphasize that none of the various 'homes' to which medicinal plants have been assigned 
provide a sufficient base of expertise for their sustainable and equitable development; and 2) to provide an 
organizational framework for the community of researchers and stakeholders, to whom this paper will be 
circulated, to think through this area of common interest and move forward together. 
This review then is a mapping exercise, which tries to identify the who, what, how, where, why and when 
of medicinal plants development in India, in order to supply a comprehensive understanding and overall 
picture to researchers, NGOs, health care workers, private companies, conservation and development agen- 
cies, 
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policy makers and other interested stakeholders. It is intended to provide a framework and knowledge base, 
and an initial way forward, for those interested in seeing India exploit her comparative advantage in the global 
market, both sustainably and equitably. 
Limits and Constraints Faced 
There is no dearth of interest in medicinal plants amongst the Indian research community. As a single 
example, the IDRC Medicinal Plants Network, a South-Asia focused initiative operating from New Delhi, 
already maintains an active database of over 900 Indian researchers and development specialists working on 
medicinal plants projects after only one year of active compilation. When a call for proposals in the field was 
issued, over 250 responses were received within the subscribed period, a tremendous number considering 
that the grants were of the magnitude of only USD 15,000. 
Unfortunately, however, this interest has not resulted in the development of a strong and high-quality 
knowledge base for the sector. Instead, one finds in a review such as this one several instances where 
information is either unobtainable or unreliable. Several factors contribute to this situation. 
The most important among these is the highly secretive and complex nature of the trade in raw materi- 
als. Most experts consulted agreed that the largest part of the trade occurs in the informal sector, and is 
absent from official statistics and trade catalogues. As previous authors have also found (see Lewington 
1993), nearly everyone involved in the medicinal plants trade is very hesitant to divulge information which is 
essential to a complete understanding --such as prices, supply sources, points of transformation, and trans- 
port routes. As a result, despite assiduous efforts, we still cannot claim to have a complete picture of the 
trade scenario, and have most likely erred in the direction of conservatively estimating the volumes of mate- 
rials under trade. 
Information available regarding the formal sector is also limited. Most data is available only in aggregate 
form, such as numbers of species being exported or overall value of the trade to India. These statistics 
unfortunately supply little information about how the market actually works, and may even obscure such vital 
information to policy makers such as seasonal fluctuations and the like. In addition, in most cases, no 
explanations are given for how the aggregations were calculated or verified (i.e. dry weights or fresh weights; 
exchange values in effect; self-reporting by companies or based on registrationwith governments, etc.). The 
lack of methodological explanation makes it virtually impossible to compare and synthesize related sets of 
information; or to understand why two sets of statistics, purporting to cover the same phenomena over the 
same time period, give differing results. 
Moreover, these statistics rely exclusively on market price as an indicator of value, a narrow approach 
which neglects environmental, cultural, personal, and long-term methods of assigning value. The social 
context of the market which is extremely important in the medicinal plants sector, 
involving as it does, a complex market spread across time and space, is there by lost. 
This constraint is related to a general lack of strategic focus in the bulk of current socio-economic 
research on medicinal plants in India. The largest group of scientists currently working with medicinal plants 
appears to be those in the natural sciences--including botanists, taxonomists, and chemists; and the applied 
sciences such as biotechnology and health care. In most instances where economic or social analysis has 
been undertaken, it has been by these same scientists, the majority of whom are untrained and unqualified to 
conduct such research. While laudable as an attempt to bridge the disciplinary barrier, this has unfortunately 
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also resulted in a generally lower quality of socio-economic analysis related to medicinal plants as against 
other resources, with analysis tending to oversimplify complex market and policy realities such as the fre- 
quently suggested solution: cut out the middleman. In addition, there is a regrettable absence of any re- 
search community or peer group working on socio-economic and policy aspects of medicinal plants, such as 
that which exists with regard to agro-technology, biotechnology, and the like, which would assist in defining 
higher standards of quality. 
Methodology 
The consequences of the absence of an extensive knowledge base is that in many places there remain 
gaps which need to be filled; where these occur, the study takes note of them. However, these have not been 
so numerous as to make it impossible to give a reasonable picture of the sector. In the absence of the usual 
sources of information for commodity studies, this review utilizes a hybrid approach following in part the model 
articulated by Arnold (1994). The review attempts to understand the market by means of the official' sources 
available regarding the macro-level trade, as well as the few well-documented case studies of the micro-level 
situation, supplemented by interviews and discussions with experts in the field who are participants in the 
IDRC Medicinal Plants Network. Where common trends and tendencies appear, they are highlighted; and 
where gaps remain, they are acknowledged. In this way, the review serves asa stock-taking not only of the 
development scenario, but of the research scenario as well. 
The review is structured to follow the medicinal plants from their origins in forests and on farms through 
to their application in formulations or as unprocessed materials. For this purpose, we have identified five 
major stages which medicinal plants may pass through on their way from collection to use. 
Different people and plants are engaged at each stage, and the review attempts to provide information on 
not only on the volumes and numbers of people involved; but also to understand which ones are involved, why 
they are involved, how and to what extent they are involved, and when they are involved, It also tries to 
understand and describe how changes at different points have affected the participation of people and plants 
at the same or other points. Such factors are of crucial importance in considering development initiatives for 
the sector. 
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Chapter Overviews 
The chapters which follow take an in-depth look at each of the stages of medicinal plant use as follows. 
Chapter One focuses on the first stage of the process, that of Collection of Medicinal Plants. Here we 
examine the current state of the resource base; the people involved in the activity and their socio-economic 
and demographic make-up; the locations at which collection takes place; the methods by which collection 
takes place; the policies and regulations currently in force pertaining to forest use and product harvesting; and 
the various interventions made in the area so far, including cultivation of plants, in-situ and ex-situconserva- 
tion, and joint forest management. 
Chapter Two follows the path of the plants to their use in the informal health care sector, where the vast 
majority are used in folk and tribal remedies. This aspect of medicinal plant use is often forgotten in analyses 
which concentrate on market opportunities or the "Big 3" (Ayurveda, Siddha, and Unani) systems of traditional 
medicine, and requires an in-depth study to understand how such market participation and promotion will 
affect local standards of health care, and how tribal and folk medicinal practices and plants can be strength- 
ened and made sustaining and self-sustainable. 
Chapter Three examines the marketing channels through which plants which are not used locally pass 
on their way from harvest to final market. It makes use of available information to characterize the different 
types of markets in which medicinal plants are bought and sold, and to understand who is involved in the 
trade. In addition, it attempts to determine the transformation points of the raw materials into products; the 
pricing patterns and determinants; the margins of profit accruing to different stakeholders; and the present role 
of the government and policy. This chapter also documents and analyzes some of the interventions of the 
state to date, such as the development of marketing cooperatives, as well as ongoing projects in commodity 
studies and market analysis. 
Chapter Four describes in greater detail the International Market briefly sketched above, with particular 
emphasis on India's performance during the past twenty years. It provides details regarding India's exports 
and imports of medicinal plants and medicinal plant-derived drugs, identifying major commodities and trade 
partners, as well as describing the present national and international regulatory environment. 
Chapter Five looks at the other major destination of plants harvested in India, that is, the country's 
domestic drug production sector. It considers the size and scope of both the traditional and allopathic manu- 
facturers, their links to primary healthcare, and the current policy environment in which they operate. It also 
documents organizations and initiatives aimed at strengthening the capacity of these manufacturers, both 
national as well as international. 
Chapter Six then takes stock of the current efforts at coordination and information in the sector, including 
networks, databases, and publications. 
Finally, Chapter Seven draws conclusions from the information presented in the previous chapters, and 
makes recommendations for the sustainable and equitable development of the sector, articulating the poten- 
tial roles that various stakeholders could play in such efforts. 
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The Medicinal Plants 
Re source Base 
Chapter 1 
The Medicinal Plants Resource Base 
11 The CuturaHistorica Context 
Medicinal systems in India date back to at least 5000 BC, coinciding with the emergence of the cities 
of the agricultural based Indus Valley civilization around 4500 BC. This civilization was, however, superim- 
posed upon earlier mesolithic hunter - gatherer societies centred in Mehrgath in the plains of Kacchi, which 
themselves bore traces of a similar society based in the Vindhyas, south of the River Ganges. While farming 
villages had emerged by 9000 BC in Mehrgath, which was situated in the transitional zone between the hills of 
Baluchistari and the Irido-Gangetic plains, settlement became more pronounced by about 5500 BC. However, 
colonization of the alluvial plains only occurred after the formation of more complex societies, firstly in the 
Indus Basin and 2500 years later in the Ganges valley. This latter delay was due to the impenetrable nature 
of this area which was densely forested and therefore unsuitable for dense human populations until the advent 
of the iron age. 
While far more is known about the food habits as opposed to the use of medicines of these early 
peoples, several factors influenced the development of medicinal systems over a period of time. 
Firstly, ethnic changes between 2000 BC and 1500 BC, resulting from the arrival of Aryan immi- 
grants, led to the domination of a new culture over the earlier pre-Caucasoid Dravidians settlers. These 
immigrants came from areas immediately north and west of the Indus valley and had links to the first city 
civilizations of Mesopotamia, for example, Sumer where, as in Egypt, medicinal systems were established. 
These influences necessarly had an impact on the development of the Vedic period with its written texts. 
A second major factor involved the trade links of the Indus valley civilization overland to Gandhara and 
Bactria in Afghanistan, as well as by sea to Persia and the Persian Gulf. Although the Persian Empire under 
Darius had already incorporated the Indus valley, some 200 to 300 years earlier, paving the way for Alexander's 
expeditionary forces, the Mauryan dynasty had united most of the country, barring the South by 250 BC. The 
resulting ties between the emerging Indian civilization and other civilizations with which it came into contact, 
must undoubtedly have affected not just trade relations but also available knowledge regarding the use of 
plants for food and medicine 
By the time of the post-Vedic period (after 600 BC), when medicine had been modified according to 
rational, scientific principles, as opposed to magical principles, the materia medica was extensive and incor- 
porated plants from neighboring regions. 
Soon afterwards, world trade, particularly with regard to spices began to intensify, both along sea 
routes as well as overland routes, resulting in linkages between the Near East and East and Southeast Asia. 
By the time of the Graeco-Roman era, pepper and ginger form India, and cassia, cinnamon and cloves from 
South East Asia, all of which were used for their medicinal properties, were widely known in the Mediterranean. 
India obtained, by diffusion rather than by trade, some important medicinal species including Cannabis 
sat/va and garlic from Central Asia; Aloe vera, Cum/num cymin urn, opium poppy and Glycyrrhiza (liquorice) 
from the Mediterranean; nutmeg from Southeast Asia; Thgonella foenum-graecum, Crocus sativus, Carum 
carvi (caraway) and Medicago sat/va (alfalfa) from Southwest Asia; Coriandrurn sativurn from the Mediterra 
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nean and Southwest Asia; Ric/nus coinmunis, So/anum ni'rum and tamarind from Africa; Acorus ca/amus 
from the Eurasian steppes; Lepid/um sativum (cress) from Tibet; and numerous other species. Most of these 
were ancient introductions. A further influx took place after the Muslim conquest of India from 1221 AD 
onwards, placing a new emphasis on the Graeco-Arab system of Medicine (Unani) which had already incorpo- 
rated elements from Egypt, Greece, Persia, India itself and China. At one point in time, approximately around 
1526 AD, the Vedic and Unani systems interacted and functioned in an integrated manner as documented by 
Bala (1982, 1985 and 1991). 
Traditional systems of medicine continued to be used in India even during the British era when western 
system were promoted due to outbreaks of epidemic diseases such as cholera, smallpox and malaria. How- 
ever, the adoption of public health measures was a novel concept, even in Britain, during this period, and as 
a result, no divergence between western and Indian medicine occurred until the ascendance of drug theory 
and practice in Europe towards the end of the nineteenth century. 
Over time other influences from the East, particularly the Chinese/Tibetan systems of medicine affected 
the medicinal cultures of numerous tribal peoples of India. More importantly, oriental medicinal plants diffused 
into diverse regions of the Himalayas and interacted with those used in the Indian subcontinent. 
Although many of the ancient as well as the more recent introductions and innovations described above, 
have become vital components of traditional medicine systems, India has over the millennia primarily relied 
on her own indigenous plant diversity in this regard. This is not surprising in light of the fact that she is one of 
the only countries to contain two of the globally identified areas of megabiodiversity, in addition to being a 
centre of origin and diversity for many crop species. The Botanical Survey of India records over 15,000 plant 
species occurring in the country, of which at least 7,500 have been used for medicinal purposes (Pushpangadan 
1995). 
Attempts to document the plant wealth of India have continued since the landmark publication by Watt 
(1889-96). Around 1700 species have been documented for their biological properties and drug action (FRLHT 
1996) and data is available for approximately 1200 species, especially those most frequently used in tradi- 
tional Indian systems of medicine, resulting in a reasonable knowledge base. However, there is still a lack of 
documentation relating to the properties, natural distribution, ecological tolerances and uses of a number of 
valuable medicinal species. Furthermore, the summaries of information which exist only provide broad as 
opposed to detailed information as shown in Table 1 .2 and 1 .3. 
Table 1 .2 Distribution of Medicinal Plants by Habit 
(based on analysis of 1079 South Indian species) 
Habit Number Percentage 
Herbs 344 32 % 
Shrubs 220 20 % 
Trees 354 33 % 
Climbers 127 12 % 
Others 34 3 % 
Source: FRLHT (1996) 
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Table 1.3 Distribution of Medicinal Plants by Parts Used 










Whole Plant 16.3 % 
Rhizome 4.4 % 
Source: FRLHT (1996) 
Before concluding this section, two areas of concern should be noted. Firstly, it has not always been 
appreciated that documentation of direct relevance to medicinal use is an international task, given the interde- 
pendence of nations in relation to research or to plant exchanges-whether for medicines, food, fibre or other 
economic purposes. Thus, for example, listing research on active principles draws on publications from scores 
of countries, including India. (Asolkar, Kakkar and Chakre 1992) 
A final relevant point by way of introduction concerns the importance of medicinal plants in international 
trade. This implies that accelerated attempts to harvest and trade materials, or to cultivate medicinal plants 
for profit, can well result in a focus on non-indigenous plants with consequent repercussions on the availability 
of the resource base to sustain national needs. 
Medicinal plant species are increasingly under threat. At present, it is feared that 15-20 percent of the 
total vascular flora of India (over 3,000 species) may fall under one of the IUCN categories of threatened, rare, 
or endangered. While a comprehensive analysis of the status of medicinal plant species has never been 
carried out, it is estimated that approximately one third of the plant species listed in the Red Data Book of 
India, may have medicinal properties (Bisen et al. 1996). 
The piecemeal efforts which have been undertaken tc assess the threat to medicinal plants bear out the 
assumption that the number threatened is high. At least 120 medicinal species have been officially classified 
as endangered (Jam 1987) and a threat assessment exercise recently carried out by an NGO in South India 
(FRLHT 1996) showed that of 78 plants occurring in the three states of Kerala, Karnataka, and Tamil Nadu 
only 21 were at low risk (Appendix 1). 
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However, what is required is specific data, for example on whether a species under threat in one region 
of the country is at low risk elsewhere, or whether estimated threats are for species which are old introductions 
from other countries (See Appendix 2) from where new germplasm could be obtained. 
The largest gap in knowledge relates to paucity of information on patterns of genetic diversity as well as 
which segments of the species' genepool/distribution need attention for conservation and for further develop- 
ment through domestication and cultivation. It is well known that certain sources of a particular species may 
be more efficacious for medicinal use than other sources. This is an area requiring strategic attention. 
The pressures exented on the resource base are to a large degree caused by overexploitation (over- 
collecting) as well as in many cases by poor collecting techniques. It is often easier to uproot the entire plant 
rather than to selectively gather the specific parts required, especially where commercial profits are available 
for the collectors. 
As result of the above factors, together with increasing populations, increased demands for crude drugs 
and lack of a comprehensive knowledge base, the continued availability of plant material from the wild cannot 
be scientifically or practically assured. 
Nor has the resource base been replaced to any significant extent by cultivation. Nearly all experts 
consulted in the field agreed that the vast majority of plants continue to be harvested from the wild, with 
estimates of up to 100 per cent for wild-harvesting in some of the predominately rural and tribal regions 
(Vedavathy, pers. comm., 1996; Nambiar, pers. comm., 1996), though usually in the order of 95 percent (FRLHT 
data for Karnataka, Kerala and Tamil Nadu). 
Even ri cases where official organizations have set up cultivation of certain species to supply external 
markets it is still inadequate. An ongoing study of the imported pharmaceutical plant materials of India's 
largest trading partner, Germany, suggests that 70-90 percent of the species acquired by the country are 
primarily wild-harvested (Lange 1996), a practice now commonly known as 'mopping.' 
The forests of India, covering 19.4 percent of the country's total geographical area, or 328 million hect- 
ares of land, form the major ecosystems for the provision of medicinal plants. Of this area, the largest 
proportions are covered by tropical wet, tropical moist deciduous, and tropical dry deciduous types. However, 
it should be noted that medicinal species are unevenly obtained not only from the different forest types but 
also the different regions of India. 
The forests of Himachal Pradesh, said to have been the birthplace of Ayurveda, are known to supply a 
very large proportion of the medicinal plant requirements of India, with one estimate quoting figures as high as 
80 percent of all Ayurvedic drugs, 46 percent of all Unani drugs, and 33 percent of all allopathic drugs 
developed in India (Aryal 1993). The Western Ghats, one of the hotspot areas of mega-biodiversity, form a 
second major supply source, While the Himalayas represent a third heterogeneous source. Unfortunately, 
however, information regarding major supply zones is often protectively guarded as a result of increasing 
scarcity of supply, and is far from being well documented. 
Additionally, not all the plant sources are Indian. It is important to note that Indian markets are heavily 
supplied by plants from surrounding SAARC countries, especially Nepal and Bhutan. These countries, 
whose processing sectors are miniscule in comparison to those of India, have supplied medicinal plants both 
legally and illegally to India for centuries. Many plants of Tibetan origin have entered India following ancient 
trade routes through the corridors of Nepal and Bhutan (Edwards 1993). 
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Table 1.4 Forest Types in India and Their Distribution 
Source: Bajaj (1990) 
The importance of these two countries in supplying medicinal plants also draws attention to the signifi- 
cance of mountain ecosystems in providing medicinal plants in India. A conference, organized in May 1996 
in Pokhara, Nepal, by IDRC, the International Centre for Integrated Mountain Development (ICIMOD), and the 
International Plant Genetic Resources Institute (IPGRI), on the role of Bamboo Rattan and Medicinal Plants in 
Mountain Development documented the great importance of medicinal plant collection in mountain environ- 
ments. Researchers at the Workshop estimated that over 120 million people in the Himalayan region rely 
primarily on plant products, mostly extracted from the wild, among which medicinal plants were one of the 
major groups (Karki, Rao, Rao & Williams 1997). 
Much more needs to be done to understand the economic pressures sustaining the trade of medicinal 
plants across borders. However, it is interesting to note that species of high attitude origin are generally of 
high value while those originating at lower attitudes are of lowervalue as the following two examples illustrate: 
Swertia c/i/ray/ta (chirayata) is one of the low-value, low-altitude plants. It is collected for a bitter prin- 
ciple active against fever and digestive disorders, with long established use in Ayurvedic medicine. It is a herb 
found at mid-altitudes (1 200-3000 m) on open ground and recent slash-and-burn forest. Most chirayata in 
Indian commerce is collected from East Nepal. India also exports the extract chiretta containing the glyco- 
side chiratin to Europe and Asia (Edwards 1993). 
Nardostachysjatamansi(jatamansi) is a high-altitude, high-value plant. It is a perennial herb from the 
alpine Himalayas (5000 m) and occurs in Nepal, Bhutan, Kashmir, Sikkim and Madhya Pradesh. The rhi- 
zomes are collected. Although non-processed exports are officially banned from Nepal, a major illegal trade 
continues to India for extraction of a pale yellow volatile oil of high value as a drug for numerous ailments, and 
an ingredient in perfumes. Interestingly this plant was listed in the pharmacopoeia of Hippocrates, a Greek 
who lived during 460-357 BC. 
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lwet 5.13 
Tropical evergreen 2.64 
Tropical moist deciduous 23.68 
Littoral and swamp 0.40 
Tropical dry deciduous 18.36 
Tropical thorn 1.65 
Tropical dry evergreen 0.14 
Sub-tropical broad leaved hill 0.28 
Sub-tropical pine 4.24 
Sub-tropical dry evergreen 1.25 
Montane wet temperate 2.34 
Himalayan moist temperate 2.20 
Himalayan dry temperate 0.03 
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1.3 The Collectors 
and theft Background 
The secrecy of the medicinal plants trade, as well as seasonal variations, make it difficult to determine 
the precise number of people involved in collecting medicinal plants from the wild. However, some data exists 
regarding collection of non-timber forest products (NTFPs) as a whole, which can provide a broad brush 
attempt to estimate those collecting medicinal plants. 
According to a study carried out in 1987 by the National Centre for Human Settlements and the Environ- 
ment in New Delhi, over 50 million people were living in and around forests in India and relying upon NTFPs for 
subsistence and cash income (NCHSE 1987). To take a single regional example, an intensive study in Tamil 
Nadu revealed that on average, more than 100,000 persons enter the forests of the state each day to collect 
forest products, including medicinal plants (Appasamy 1993). 
All available evidence suggests that it is the poorest of the poor who rely on the harvesting of NTFPs, 
such as medicinal plants, for their earnings (Godoy and Bawa 1993; Appasamy 1993). This is particularly the 
case where people have had relatively unrestricted access to forests as common property resources: the 
plants are easily accessible, and the markets do not demand a high level of processing or related skills 
(Edwards 1993). Table 1 .5 illustrates divergences between high and low income groups in terms of depen- 
dence on NTFPS. Common property resources are a vital component of income for the poor, which, if dimin- 
ished, would exert a major impact on their ability to meet their most basic survival needs. 
The role of women has also begun to receive a significant amount of attention from those involved with 
medicinal plants as well as with alternative approaches to forest development. It is widely held among the 
papers and case studies obtained during this study that women play a major role in collecting, and in some 
cases marketing medicinal plants, especially since these activities coincide with their basic responsibilities 
of providing health care to children and families (Nambiar, pers. comm. 1996; Vedavathy, pers. comm. 1996; 
Arnold 1994; Pokhara Declaration). While men living in and near forests tend to be involved with the higher 
income-generating timber trade, anecdotal evidence suggests that women have been a major force in the 
collection and utilization of products such as medicinal plants. However, research findings which thoroughly 
consider the extent and nature of women's participation are not yet available. 
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Table 1 .5 Degree of Dependence by Rich and Poor on Common Property Resources 
























































Source: Jodha (1990) 
There is a close relationship between medicinal plants and other NTFPs in the lives of those who collect 
them. Case studies have revealed that, collection of medicinal plants has typically comprised one component 
of a number of livelihood strategies pursued by forest and fringe dwelling communities. Activities which 
usually accompany collection of the plants include collection of other NTFPs such as resins, gums, bamboo 
and cane, honey, and the like (Godoy and Bawa 1993). In addition to these extractive activities, many case 
studies have indicated that the families involved are also active in the agricultural sector. 
Table 1 .6 depicts the contribution of various rural activities to the livelihood security of a small tropical 
Sri Lankan village studied in 1992 (Gunatilake et al. 1993). Medicinal plants contributed approximately 24 per 
cent of the total family income; while livestock contributed 35 percent; cardamom collection 33 percent, and 
a range of other activities made up the remaining income. Significantly, these figures are averages, and both 
incomes and labor inputs from different activities would vary from season to season. It is likely that a similar 
situation would be found in India. 
In addition to recognizing that medicinal plants usually comprise only one of a number of income- 
generating activities of the collectors, it is also important to note that research outside the South Asia region 
suggests that extraction of medicinal plants and other non-timber forest products is a job of necessity rather 
than of choice, and that it may be only a stand-by until more profitable means of making a living, are available, 
particularly through livestock and agriculture activities (Browder 1992). As noted in a survey of NTFP case 
studies conducted in 1993, the richer households and villages become, the less time they tend to spend 
collecting medicinal plants and other NTFPs; instead, they turn to more attractive non-forest based occupa- 
tions such as agriculture and business enterprises (Godoy and Bawa 1993). 
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Table 1.6 Contribution to the Total Income By Each Activity 
of the Farming and Forest Collection System 
Activity Participatin households % contribution to Average contribution 
# % total 
income to income 
($/family/year) 
Rice Cultivation 












































Source: Gunatilake et. al., (1993) 
In fact, according to the same survey, richer households and villages tend to: a) extract fewer plants and 
animals; b) spend less time foraging and more time in non-forestry occupations; C) consume fewer wild plants 
and game; and d) use more domesticated animals and industrial substitutes (Godoy and Bawa 1993). 
This has very important implications for development projects which seek to capture greater benefits 
locally from medicinal plants, suggesting that livelihood choices are very susceptible to change, and that 
participation will depend upon trade-offs, given the informal and opportunistic nature of the market. 
An additional consideration is the possibility that as these products become more valuable, especially 
medicinal plants, their access will tend to be monopolized by the richer segments of society. Access to 
markets, political authority, and the like, can enable the rich to divert the flow of medicinal plants so that they 
are better served and provided for by these, while the poor forest-dwellers lose access to the resources as 
they become more valuable (Dove 1994). Medicinal plant collecting, in other words, could go the way of timber 
ri moving from a poor man's source of income to that of a rich man; and even, from a poor man's source of 
medicine to that of a rich man. 
There are virtually no known comprehensive studies regarding the methods by which medicinal plants 
are harvested from the wild. However, conventional wisdom holds that the collecting methods are unscientific 
and unsustainable, with estimates as high as 70 percent of the plants being destructively harvested (Godoy 
and Bawa 1993, FRLHT 1996). 
Methods of collection also vary in relation to who is collecting the plants and for what use. Godoy and 
Bawa (1993) have suggested that plants destined for local use by the collector or his immediate society tend 
to be harvested more sustainably than those destined for commercial markets. Tribal groups and 
those with close connections to the forest and land are also reported to use very sustainable methods of 
extracting medicinal plants for use in their own formulations, in some cases including elaborate rituals which 
are designed specifically to promote the health and future yields of the plants. (Vihari 1996; Vedavathy 1996). 
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In addition, it has been found that poor villages tend to extract low volumes of a number of forest 
products of low value; whereas richer villages remove greater volumes of fewer goods of higher value. This 
intensification or specialization by the wealthier groups is due to fact that richer groups tend to be less reliant 
on forests for subsistence needs, and can therefore focus on high-value, low-volume products such as 
medicinal plants, which provide the highest remunerative gains (Godoy and Bawa 1993). 
t4 The Pocy En•viro rment 
Common Property and Forest Access Laws 
Although in numerous parts of India, forests have in effect been managed as common property re- 
sources since time immemorial, this has not officially, been the case since 1878, when the colonial govern- 
ment legislated the Forest Act, dividing forests into three categories which even now continue to be used: 
reserved forests, protected forests, and village forests. Reserved forests and protected forests were under 
the jurisdiction of the Forest Department, and constituted by far the largest portion of forest lands in the 
country. The difference between reserved and protected forests lay in the use of resources, which in reserved 
forests was tightly restricted, whereas in protected forests, Forest Department officials were allowed to make 
use of the resources for purposes which were seen to benefit the colonial economy. 
The concept of village forests entailed that communities dwelling in or near forest areas should have the 
right to make use of them. The village forests were thus under the control of the village Panchayat, a semi- 
democratically comprised council which still prevails in Indian villages. However, though officially under local 
control, in practice the state could still override the decisions of the village. This situation continued even after 
independence, and in fact, the National Forest Policy Resolution of 1952 specifically stated that the claims of 
communities in and around the forests could not override 'national interests.' 
Jodha (1990) has shown that from 1952 to 1982, common property resources declined dramatically, 
even as population pressure increased. As Table 1 .7 shows, in all of the seven States studied, there has been 
a dramatic increase in persons per hectare of common property resources; in several states, this number has 
increased nearly threefold during the survey period. 
As it became apparent that local needs frequently could not be met without some degree of control being 
exerted over the local resource, a movement began to ensure that forest policies were more in line with 
peoples' actual needs. In 1982, a Report of the Committee on Forests and Tribals stated that three areas 
must be addressed by forest policy: ecological security; products used for food, fodder, fibre, timber, and other 
domestic needs of the rural and tribal populations; and materials used by cottage, small, medium, and large 
industries (Appasamy 1993). This was an attempt to shift the focus of forest policy away from the 'sustained 
yield' concept which mainly benefitted large-scale industry, and to emphasize forests as a means of meeting 
the needs of a variety of stakeholders, including forest-dwellers and future generations. 
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Table 1 .7 Decline in area of common property resources (CPR) and increase 
in population pressure on them 
State 
Average area of 










































Source: Jodha (1990) 
The 1982 report described above was actually incorporated to some extent at the policy-making level 
while the 1988 National Forest Policy specifically addressed many of the issues concerned. One section of 
the policy read, "the life of the tribals and the other poor living within and near forests revolves around forests. 
The rights and concessions enjoyed by them should be fully protected, their domestic requirements of fuelwood, 
fodder, minor forest produce and construction timber should be the first charge on the forest produce." Unfor- 
tunately, however, the Forest Policy is not a legal enactment, serving rather as a set of guidelines for interpret- 
ing the laws. This leaves the rights of forest-dwelling communities to some degree of control and access to 
forest produce legally unprotected in most cases and vulnerable to strong-arm tactics used by state and local 
forest departments, as well as by industry. 
At the same time, policy makers at the state government level have in many cases attempted to ensure 
access to the forests by tribal and other poor communities. In Kerala, for example, under the Monopoly 
Procurement and Marketing Polic' Act of 1978, permission was given to tribal and tribal societies to collect 
120 items from the forests, of which 73 were known to be medicinal plants. Unfortunately the collection 
monopoly in this case was of questionable benefit since only 15-25 items were actually collected due to the 
fact that the prices obtained for the remaining items were not remunerative (Santhosh 1996). 
Similar policies are known to have been enacted in other states, frequently linked to government-oper- 
ated marketing cooperatives. Unfortunately, these legally monopolistic (only tribals sell) and monopsonistic 
(only cooperatives buy) markets have tended to fail and have rarely allowed the poor communities they 
intended to serve to actually benefit from their harvesting from the forest, as further discussed in Chapter 3. 
Forest Products Regulations 
In terms of policy, medicinal plants have generally been lumped into the broad category of Minor Forest 
Produce (MFP). Even the relatively progressive 1988 Forest Policy Resolution continues to use this terminol- 
ogy. However, as the markets and sizes of the user communities suggest, a more accurate designation for 
these products would be Non Timber Forest Products (NTFPs), which has recently gained widespread recog- 
nition around the world. 
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Nonetheless, NTFPs, including medicinal plants, have rarely been considered as warranting the enor- 
mous amount of consideration and research given to timber policies. However, some provision for regulation 
was made as early as 1927 under the Indian Forest Act. This Act defined two types of forest produce, for 
which permits, registration, and licensing were required when collected and traded: 
Section 2 (4) (a) regulated selected forest products, regardless of their origin in forests or elsewhere; 
for the most part it identified tree species used for timber; 
Section 2 (4) (b) regulated all non-tree plants, all parts or produce of such plants, including leaves, 
flowers, and fruits and all parts or produce of trees not specified in the first category, but only when originating 
in a forest. 
Most medicinal plants are covered under sub-section (b), and are not subject to regulations unless 
extracted from the forests. However, some items such as bark and wood-oil from certain trees were covered 
under sub-section (a); and subsequent state amendments to the Act have added several medicinal species to 
this sub-section, as shown in Table 1 .8, subjecting to significant regulation regardless of origin. 
Additionally, in some cases complications associated with management of the different types of forests 
described earlier can become burdensome and overwhelming to the collectors of the plants. One such case 
from the Central Himalayan forests was documented in 1993. The government had recently come under sharp 
criticism by the Forest Panchayat of the village Khaljhuni, regarding the commercial exploitation of MFP. The 
detailed and laborious procedure of gaining government permits was found to comprise 13 percent of the total 
costs faced by the villagers in extracting MFP. This situation encouraged illegal extraction, in addition to 
increasing opportunities for (greed) and corruption on the part of bureaucrats, at the villagers' expense (Rao 
and Saxena 1996). 
Table 1.8 Medicinal Species Included by State Amendments 
in Section 2 (4) (a) of 1927 Indian Forestry Act 
Gujarat Rauwolfia serpent/na, Kadaya gum 
Maharashtra Rosha grass including oil, Rauwo/fia serpent/na 
Karnataka Sandalwood oil, rosha grass and oil, Phy/lanthus emb/ica, 
Term inalia chebula, Terminal/a be/er/ca, Cappañs moon/ 
Tamil Nadu Sandalwood 
Kerala Gum, fibres and roots of sandalwood and rosewood 
Orissa Gums, roots of Patargaruda, sandalwood, tamarind 
Uttar Pradesh Gum, Chiraunji 
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Most of the produce of cultivated medicinal and aromatic plants is exported as crude drugs e.g. Psyl- 
I/urn, senna leaves, opium poppy and Asgand. Unfortunately, however, due to emphasis being placed on 
important cash crops, as well as the fact that the majority of the cultivated species are not indigenous to India, 
most cultivation efforts are not alleviating the pressure being exerted on the natural resource base. 
Nevertheless, a number of techniques have been developed to increase the quality and yield of many of 
the cultivated species. It is estimated that Indian public sector research institutions have developed stan- 
dardized practices for the propagation and agronomy of a total of about 40 species (Chadha and Gupta 1995; 
(FRLHT 1996). 
Public Sector Research Efforts 
Much of the research progress to date has resulted from the decision of the Indian Council for Agricul- 
tural Research (ICAR) to establish an All-India Coordinated Research Project on Medicinal and Aromatic 
Plants (AICRPMAP), in 1972, under the auspices of the National Bureau of Plant Genetic Resources (NBPGR). 
Efforts have mainly focused on the development of agro-technology techniques, including propagation meth- 
ods for medicinal and aromatic plants. Aromatic plants have however tended to receive more attention, per- 
haps because their market values are in general more widely known. 
ICAR works through a network of research stations, including the National Research Centre for Medici- 
nal and Aromatic Plants located in Anand, Gujarat, which specializes in domestication, and has created 
structural links between the NBPGR and its Plant Breeding Division in order to develop improved varieties of 
some of the medicinal plant species used in allopathic preparations. 
Another major national public research organization, the Council for Scientific and Industrial Research 
(CSIR), has also played a significant role with regard to cultivation of medicinal plants, through its creation of 
CIMAP, the Central Institute of Medicinal and Aromatic Plants, in Lucknow. CIMAP is now a preeminent 
institution in India focusing on agro-technology as well as basic studies; improvement and enhancement of 
the resource base, and chemistry and related research regarding product development from plants. Priority 
species are also frequently aromatic plants. To illustrate the current research focus those species accorded 
priority for rapid clonal propagation and genetic manipulation are listed in Appendix 4. 
In connection with the two major research efforts described above, the Central Government initiated a 
five year program (1992-1997) implemented by the Ministry of Agriculture to accelerate research and develop- 
ment of medicinal plants. With the support of 16 state agricultural universities, state horticulture and agricul- 
ture departments, regional research laboratories and the International Crop Research Institute for the Semi- 
Arid Tropics (ICRISAT), the GOI is establishing herbal gardens, nursery centres and demonstration seed 
production centres nation-wide. 
Private Sector Research Efforts 
Private companies have also begun to invest in the cultivation of medicinal plants, since they face 
difficulties with regard to increasing supply gaps as well as in some cases adulterated materials from the wild. 
One such company, the Arya Vaidya Sala, in Kottakal, Kerala, in addition to maintaining two large herbal 
gardens, has also undertaken research on the propagation of 10 species, the demand for which currently 
outstrips supply, or may soon do so. 
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Table 1.10 Species Under Agro-technical Research by the Arya Vaidya Sala, 1995 
Species Number of formulations in which Quantity demanded annually 
species is utilized by AVS by AVS (kg) 
Bal/osperinum montanuril 27 1000 
Celastruspan/cu/atus 15 540 
Cosc/n/um fenestraturn 70 3300 
Crateva nuivala 13 1840 
Emb//ca ribes 75 3030 
Hem/desmus ind/cus 30 19000 
Holostemma ada -kodien 40 3860 
Rub/a cordifo//a 40 4200 
Saraca asoca 3 5310 
Tr/chosanthes lobata 32 5800 
Source: Bajaj and Williams (1995) 
A comparison of the species depicted in Table 1 .10 with those shown in Appendices 2 and 3 reveals that 
there is no overlap in research efforts and that the AVS venture is complementary to that of the government. 
Further, the AVS venture which has been undertaken with funding by IDRC is encouraging the participation of 
farmers, who are now enthusiastic about cultivating medicinal crops, and is investigating the potential of 
intercropping the selected medicinal species with other economically viable species to create an added incen- 
tive for farmers. 
Other traditional drug manufacturers in India have also begun to invest in cultivation experiments and 
developments. Some of the companies are undertaking R&D programs through the creation of company 
foundations, such as the Zandu Foundation for Health Care in Mumbai and the Shree Dhootapapeshwar 
Ayurvedic Research Foundation in Bangalore and Panvel. These companies are actively involved in the 
development of cultivation methods of medicinal plants of importance to them, with the direct participation and 
partnership of local farmers and tribal women. (Lambert 1996). All such efforts Will result in an increase in the 
number of medicinal plant species cultivated, particularly indigenous Indian species. 
Ex-Situ Conservation 
Establishing collections of medicinal plant gemplasm is another means of helping to maintain the re- 
source base. At present such collections include those designated as genebanks as well as herbal gardens. 
Many of these are scientific reference collections of species, as are specimens of medicinal plants grown in 
botanical gardens. For the collection of living plants to constitute a major conservation field genebank, a wide 
range of intraspecific diversity is needed, well documented in relation to its origins and uses. However, there 
is no comprehensive documentation available on existing collections to ascertain to what extent they act as 
ax s/tu collections or as sources of planting materials. Nonetheless, the list of major collections described 
below (and in Appendix 5) highlights the interest and activities being devoted to this area. 
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Herbal Gardens 
India has joined the G-15 Gene Banks for Medicinal and Aromatic Plants (GEBMAP) initiative, and 
currently acts as the coordinator for the Asian countries in the network. Three gene banks have been estab- 
lished in the country; one through the Central Institute for Medicinal and Aromatic Plants in Lucknow; one 
managed by the National Bureau of Plant Genetic Resources in New Delhi; and one coordinated by the 
Tropical Botanical Garden and Research Institute, Trivandrum. The Department of Biotechnology is the nodal 
agency to which this work has been assigned. 
The Tropical Forest Research Institute (TFRI), Jabalpur, has established a herbal garden with a 
collection of 461 species, including rare and endangered species (see Appendix 6). Emphasis is on 
propagation for large-scale cultivation of species with market potential, and rehabilitation of species 
on the verge of extinction. 
The Forest Research Institute at Dehra Dun has collected significant medicinal and aromatic plants 
of the Himalayan region and is using the NWFP nursery at Chakrata and the botanical garden at 
Dehradun to produce large numbers of plants. Cultivation and harvesting techniques have been 
standardized for a number of these plants. The following rare and endangered species were ear- 
marked for protection in the garden: Taxus baccata, P/crorhiza kurrea, Nardostachys jatarnansi 
Orch/s lat/fo/la, Crocus sat/va, Bun/urn persicurn. 
The Department of Indian Systems of Medicine and Health, Ministry of Health and Family Welfare, 
has promoted the establishment of small herbal gardens in educational institutions as a means of 
furthering traditional medicine systems. 
The Central Council of Research in Ayurveda and Siddha situated in Pune maintains a Medicinal 
Plant Garden, which houses 320 species of medicinal and aromatic plants, including a number of 
endangered species. 
It is not clear to what extent the collections overlap, and how far they address the conservation needs of 
the country. Almost certainly, an assessment is needed and the strategy being pursued requires definition. 
The responsible organizations include several GOl departments, as well as international agencies with an 
interest in this feld such as G-1 5; IUCN; WWF; Botanic Gardens Conservation International, IDRC, Canada, 
and some the UN Agencies. 
In-Situ Conservation 
Several institutions, including ICFRE, TFRI, the Forest Survey of India, the Botanical Survey of India, 
and CIMAP, have conducted vegetation surveys revealing continuing losses of the medicinal plants resource 
base (Tewari 1996). Additionally, several meetings of experts organized in the region have called for ajudi- 
cious mix and balance of ex-s/tu and /n-situapproaches to conservation: IDRC, for instance has in the past 3 
to 4 years repeatedly stressed this need (Bajaj and WiUiams 1995; Tirupati Declaration 1996; Karki, Rao, Rao 
& Williams 1997). 
Government Initiatives 
/n-sftu conservation of biodiversity has for some time been given priority by the GOl although it is still 
too early to assess the success of its initiatives in protecting biodiversity and their consequences for local 
means of income generation and land access. 
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The government created forest preservation plots in 1905 and since then has established them through- 
out the diverse forest ecosystems of India. These include 65 national parks, 426 sanctuaries, 13 biosphere 
reserves, 316 preservation plots and more than 7200 sacred/religious groves. This network covers more than 
5 percent of the nation's geographical area, and is coordinated/monitored by the Ministry of Environment and 
Forests (Bhatnagar and Bisen 1996). It has been strengthened on numerous occasions, most notably through 
the Forest (Conservation) Act of 1980 and the Conservation of Forests and Natural Ecosystems Act of 1995. 
The extent to which the network protects India's medicinal plant biodiversity is however not well understood 
due to the need for inventory and documentation. 
The Wildlife (Protection) Act of 1972 refers mostly to the protection of species within the protected areas 
network, with only a small number of plant species being covered regardless of location. The only medicinal 
species among these is kuth, which is also a restricted species identified by the Convention on International 
Trade in Endangered Species (CITES), covered in more detail in Chapter 4. 
However, a policy dialogue has been initiated regarding medicinal plants conservation, and statements 
of support for such a policy are forthcoming from many of the stakeholders in the sector, including the private 
companies which depend upon a continuous source of raw materials supply (Lambert 1996). More recently a 
meeting of governmental, non-governmental, and private sector representatives was held at the M. S 
Swaminathan Research Foundation in Chennai in 1996, in order to begin the long process of developing and 
enacting national policy. 
Non-Government Initiatives 
A key organization involved in mobilizing a movement for medicinal plants conservation policy is the 
recently-formed Foundation for Revitalization of Local Health Traditions (FRLHT), with headquarters in Banga- 
lore and funded by DANIDA. FRLHT established a coordinated network of 30 in-situ research areas in the 
states of Tamil Nadu, Karnataka and Kerala between 1993 and 1997. These medicinal plant conservation 
areas, (MPCAs) average 200 hectares in size, and are located within notified forest reserves or wildlife sanc- 
tuaries (FRLHT 1995). They are listed in Appendix 7. 
Many of the MPCAs have contiguous forest communities whose cooperation and involvement benefit 
these in-situ conservation sites. With their assistance, unwanted animal grazing and accidental fires which 
may damage the flora of these reserves can be prevented. To ensure that the MPCAs continue to exist in the 
long-term,FRLHT has obtained commitments from the State Forest Departments involved to maintain them 
beyond the duration of the project. 
Joint Forest Management 
Achieving the empowerment and involvement of people is also the primary thrust of a growing move- 
ment in India known as Joint Forest Management (JFM). JFM refers to cooperative agreements made be- 
tween village communities and the local forest departments to protect a particular area of state-owned forest 
land and then share the final harvest (Sundar 1996). As such, it offers an approach which allows communities 
to have a greater degree of control and access to state-owned lands, and enables them to benefit more than 
from predominant tenure and forest property policies. 
Started in the Arabari Hills of West Bengal by A. K. Banerjee in the 1 970s, JFM has proved to be a novel 
and workable concept in achieving the combined objectives of development and conservation. In 1990, the 
Ministry of Environment and Forests wrote to the Forest Secretaries of all States and Union Territories, 
requesting them to actively encourage participation of communities in rehabilitation of degraded forest areas, 
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and to attempt to replicate successes. Although many areas have been slow to adopt JFM (Guha 1994), it 
is estimated that 10,000 to 15,000 village forest protection and management groups are currently protecting 
over 1 .5 million hectares of state forest lands (Sundar 1996). 
Although not extensively documented, medicinal plants and other NTFPs have a potentially important 




and Indigenous Uses 
Chapter 2 
Traditional Knowledge and 
Indigenous Uses. 
In order to understand the extent to which medicinal plants are used at the local community level, a 
useful distinction can be employed related to the type of medical practice: 
AIIopathi, generally understood as 'modern' medicine, and based predominantly on the prin- 
ciples of Western Post-Enlightenment Science which has dominated the last three centuries. 
Classical Traditional, referring to the documented and standardized "Great Tradition" systems 
of medicine, including (in India) Ayurveda, Siddha, Unani, Amchi, and Homeopathy, with different 
epistemological bases to that of Western Science. 
Folk Traditional, referring to those medical practices which are usually transmitted orally from 
generation to generation and whose use is generally confined to a particular geographical region or 
group of people such as a tribe or caste community. 
Most studies and common wisdom in India suggest that few people adhere solely to any one of these 
types of medicine, more often shifting from one to the other, based on a combination of factors including 
preference, faith, availability, and cost. A recent study by the Ministry of Health and Family Welfare, con- 
cluded that less than 30 percent of India's population is adequately served by modern medicine and the 
primary health care centres which were meant to reach the most remote areas. The organized Indian systems 
of medicine (ISM) are said to have similar levels of penetration. Hence it has been asserted by some that up 
to 500 million people continue to take recourse to some form of traditional folk medicine, including local 
innovations on classical systems (FRLHT 1995). 
Although this assertion cannot be conclusively proven, there is information to suggest that it may be 
correct. According to the Anthropological Survey of India, there are over 4,635 tribes spread throughout the 
country, most of whom live near forests and depend upon their resources to fulfil basic needs. In addition, the 
majority of India's population of nearly 1 billion continues to be rural and village-dwelling, frequently isolated 
from the usual means of medical knowledge transmission. Taking these factors into account, an estimate of 
500 million does not seem exaggerated. 
While microstudies conducted in South Asia reveal the existence of a large number of practitioners, 
displaying various levels of specialization, an shown in Table 2.1, millions of households still practise self 
medication using locally available remedies based on medicinal plants. 
A large number of species, many of which are indigenous to the South Asian region are used in these 
preparations, which are themselves unique to India in many cases. The GOl has in recent years been active 
in placing medicinal plants within the broader context of ethnobotany through an All-India Coordinated Re- 
search Project on Ethnobotany under the Ministry of Environment and Forests. The resulting findings are 
also of interest to private companies, mostly foreign-based, which are seeking to develop new drugs. 
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Table 2.1 Some Practitioners of Folk Traditional Medicines in South India * 
Housewives and Mothers Home remedies food and nutrition Millions 
Traditional Birth Attendants Normal deliveries 700 000 
Herbal Healers Common ailments 300 000 
Bone Setters Orthopaedics 60 000 
Visha Vaidhyas Natural Poisons 60000 
Other Specialists Skin respiratory mental illnesses 
arthritis dental wounds liver, 
fistula piles 
*Based on extrapolations from micro-studies. Source: Sankar (1994) 
Information about tribal and folk practices assists these companies in identifying prospective plants for 
future drug manufacture. In recent times, such 'biopospecting' companies have attracted a great deal of 
attention, both positive and negative, at international fora, especially at the UN Conference on Environment 
and Development in 1992 and at subsequent discussions. What is clear is that the pharmaceutical industry 
whether international or national will continue to benefit from traditional knowledge, since many pharmaceuti- 
cal products have been derived from plants-some 75 percent of these were discovered by examining the use 
of these plants in traditional medicine (Tempesta and King 1994). Indeed, it has been shown that through 
consultations with indigenous peoples, the success rates from bio-prospecting can be increased from approxi- 
mately 1 in 10,000 to even 1 in 2 (Anon 1995). 
Such considerations of benefit to pharmaceutical industries should not however cloud the major re- 
search objectives stated by WHO: since the therapeutic practices based almost entirely on the use of tradi- 
tional herbal remedies are prescribed by traditional medical practitioners, who are respected members of the 
community, the government has responsibilities to formulate national policies that encourage the national use 
of herbal medicines and to promote their safety and quality (WHO 1991, 1993). A WHO/IUCN/WWF Interna- 
tional Consultation on Conservation of Medicinal Plants noted that the loss of indigenous cultures has direct 
consequences on the identification of new medicinal species to benefit the wider community (Akerele t 
1991). 
Growing urbanization and changing cultural preferences, the overexploitation of the plant resource base 
upon which traditional medicine depends, and the lack of organized support and activity with regard to folk and 
tribal medicine, have led most experts working in this field to conclude that these traditions are slowly dying 
out (Bajaj and Williams 1995; Vedavathy, pers. comm. 1996). 
Traditional uses of medicinal plants may also decline due to increasing commercialization of the medici- 
nal plant sector, and diversion of raw materials for sale in markets. One study conducted in Arunachal 
Pradesh examined the use of Mishmi tita (Capt/s teeta), a bitter root that isfourd at attitudes of between 2000 
meters and 3000 meters in the districts of Dibang and Lohit. Over the last decade, local people have been 
selling the species for a very remunerative price of Rs. 1000 per kilogram locally, after which it is exported via 
Calcutta to Japan and Switzerland. Though this plant was traditionally used by tribals for the treatment of 
fever, backache and dysentery, it is now being substituted by opium for local use due to the fact that all 
available supplies are for export, (Aryal 1993). The fact that other locally available species such as kutaya 
(Hollarrhena ant/dysenterica) and Barber/s are not being substituted is an indication of the locally specific 
nature of traditional knowledge. 
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Traditional Knowledge and Indigenous uses 
What is surprising, however is that most studies relating to folk and tribal medicine have concentrated 
more on the practices themselves, in isolation from the social and economic context in which they occur. 
Manuals and publications of ethnobotanical studies tend to be primarily lists of plants with brief descriptions of 
their methods of use. In most cases, little information is included regarding the number of people knowledgable 
about the practices, or the demographic make-up of both the practitioners and the users of the medicines. 
The logic of the practice as understood by the practitioners themselves, as well as important associated 
rituals apart from drug administration, for example methods of collecting and processing, are also rarely 
reported. 
2. . i ir h. P' V • fl ni en t 
Policy implications relating to the traditional knowledge base of indigenous peoples on medicinal plants 
and health care are complex due to the fact that they are coloured by debates on biodiversity conservation 
imperatives, knowledge systems for drug discovery, intellectual property rights/patents and equitable sharing 
of benefits derived from indigenous knowledge. Although India is committed to the Convention on Biological 
Diversity, questions of equity are yet to be fully addressed. The proposed UN Declaration on the Rights of 
Indigenous Peoples, as well as the activities of the International Labor Organization and the General Agree- 
ment on Trade and Tariffs (GATT) all impinge on national policy development in this area. It will therefore be 
some time before policy is formulated and practical applications developed. The latter are likely to devote 
attention to encouraging collaboration between all concerned parties in order to foster respect for the contribu- 
tion of indigenous knowledge, as well as to ensuring that regulations take local laws and customs into account 
in the utilization of biodiversity. 
It is also imperative that GOI policies regarding the use of medicinal plants in health care are compre- 
hensive period in their coverage in order to encompass all of the different types of medicine-allopathic, clas- 
sical traditional and folk traditional. 
Although they may constitute the largest part of health care provision among India's population, espe- 
cially among the poor, tribal and folk practices are still not recognized by GOI policies dealing with health care 
or medicinal plants. However, these policies do recognize the value of the classical traditional systems. 
Furihermore, tribal practices have begun to assume greater importance in recent years due to the current 
debate on intellectual property rights and the potential implications of bioprospecting. 
There is however a danger, as articulated by several NGOs, most notably the Third World Network led by 
the Indian scientist Vandana Shiva, that new possibilities for the exploitation of the poor, will be created by the 
Trade Related Intellectual Property (TRIPS) stipulations attached to GATT. India is a signatory to GATT and 
has agreed to comply with the stipulations in principle, although a good deal of internal debate continues with 
regard to who should obtain universally valid patients as well as the benefits which should accrue to the 
communities providing the input knowledge. 
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22 Interventions to Date 
Government resources tend to have been unevenly allocated to those sectors of health care which 
utilize medicinal plants. Thus, the classical systems of Ayurveda, Siddha and Unani have received consider- 
able attention, as has allopathic medicine. Furthermore, issues relating to the domestic and international 
marketing aspects of medicinal plants, as well as the need for wider ethnobotanical documentation are also 
being addressed. 
Nonetheless, the All-India Coordinated Research Project on Ethnobotany which works to identify and 
document plants used by various ethnic groups has shown that a great deal needs to be done before the 
relevant pharmacopoeia is developed and is accorded the same priority as those developed for other sys- 
tems. It is worth noting that over 65 percent of tribal areas have been surveyed, and a database of the plants 
used in tribal medicine is being developed (see Appendix 8). 
Recognizing the constraints related to tribal medicine, the IDRC Medicinal Plants Network (IMPN) spon- 
sored a South Asia Regional Conference on Tribal and Folk Plant-Based Medicines, in September 1996, which 
was attended by experts on tribal and indigenous culture and medicine, economic botany, ethnobotany, forest 
and agricultural resource management, pharmacology, public health, and socio-economic development, from 
India and some of the surrounding SAARC countries. 'The stated aim of the conference was to formulate an 
action plan for the development of sustainable and self-sustaining tribal and folk medicinal systems, and to 
this end participants drafted and endorsed a Tirupati Declaration" which outlines clear and concrete steps for 
achieving this goal (see Appendix 9). Some of the areas which require policy development are raising the 
status of tribal and folk medicine as an effective health care resource; sustainable management of the re- 
source base; equitable sharing of benefits and increased livelihood security for the poor. 
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The Marketing Channels: From Harvest to Market 
While Chapters 1 and 2 of this report provided background information on the medicinal plants resource 
base and its uses, the following chapter focuses on the commercial aspects of medicinal plants entering the 
market. Although the dearth of high quality research poses constraints on the extent to which overall conclu- 
sions can be drawn, it is still possible to provide an outline of the main actors involved; their transactions; 
points of transformation of the raw materials; prices, and profit margins accrued in the trade, on the basis of 
available data. 
3i The Main Actors in the Trade 
Available case studies and published analyses (including Majumdar 1991; Dobriyal, et al. 1995; Olsen- 
Smith 1996; Arnold 1994; Chandan, pers. comm. 1996; Edwards 1993; Lokamanyan; Bajaj and Williams 1995 
and Aryal 1993) suggest that there are five categories of actors involved in the marketing channels for medici- 
nal plants, from their movement from the forest or farm, to their final export or consumption as drugs or herbal 




Wholesale Dealers and 
Final Consumers. 
With the exception of the collectors, who have been mentioned in Chapter 1, there is very little informa- 
tion available by which to characterize the market actors. It appears from relevant studies conducted on this 
subject that men are the primary participants in the market beyond the collection stage, with no mention being 
made of women's roles as agents, contractors, or wholesale dealers. Furthermore, important socio-economic 
data relating to the social and economic backgrounds of traders, agents and dealers, including questions of 
whether or not they belong to the same families or castes, or are regionally affiliated, is not generally available. 
In addition, little is known of the role played by the medicinal plants trade in the overall livelihoods of 
those involved-from the private agents through to the final consumers. It is unclear from published information 
whether traders tend to specialize in medicinal plants, or whether, like the majority of the collectors, they are 
involved with additional commodities or primarily work in altogether different occupations. This information-- 
which would reveal the extent of each of the actor's stakes in the market--is extremely important in order to 
understand and assess their relative contributions and needs in medicinal plants development. 
Finally, since the numbers of people involved under each of the categories described above are difficult 
to estimate, the degree of concentration of the market at various stages of the process cannot be discerned. 
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32 The Chain of Transactions 
A major reason for the information gaps described above is the highly secretive nature of the medicinal 
plants trade. Although it is difficult to procure reliable information regarding the people, plants, and paths 
involved in the marketing channels, it is nevertheless possible from the information available, to discern a 
general--though not universal--path of transactions followed by medicinal plants. 
Before discussing the various stages of the marketing process, it is important to note, that many, and 
perhaps most, medicinal plants will not follow this exact path. In some cases, there may be multiple sales 
from one market(niandi)-based private agent to another, or else the products may be directly supplied by the 
marketgent to the final consumers. In addition, trade activities may move in and out of both the formal 
sector, as well as the legal boundaries at various points of the chain of transactions. 
What frequently sets the chain of transactions in motion are advance orders placed by wholesale 
dealers in the large urban markets to private agents, usually based in comparatively smaller markets which 
may be situated at considerable distances from the wholesaler's location. These private agents then employ 
petty traders who visit the local markets. 
Except where associated with agricultural products or other forest goods, local markets are rarely round- 
the-clock establishments. Rather, they may be weekly or otherwise regularly-timed haats, usually held at the 
village or multiple-village level. Petty traders visit these markets and buy directly from the collectors/farmers 
or their representatives. The purchase of medicinal plants is generally based on fresh weights, although some 
traders prefer to use dry weights. 
The petty traders then forward these items to the district level markets, or mandis, for sale to private 
agents, known as arhat/yas. These agents are versatile and well organized: they are conversant with rates in 
rnand/es throughout the state, as well as with the prevailing rates in the larger markets. 
Final transactions generally take place in very large markets located in the urban centres. Currently the 
major known markets for medicinal plants are found in Amritsar, Calcutta, Chennai (Madras), Cochin, Delhi, 
Kanpur, Mumbai (Bombay), and Tuticorn (Bhatnagar and Bisen 1996; Chandan, pers. comm. 1996; Olsen- 
Smith 1996). High-volume buyers purchase the products from wholesalers to supply Indian production indus- 
tries, or the international market. 
Given that most of the trade occurs in the informal unorganized sector, and that whatever little occur in 
the formal sector suffers from a great deal of false reporting and poor record-keeping, it is virtually impossible 
to assess the current volumes of trade in the domestic marketing channels. However, expansion of the 
volume of trade seems indisputable. 
In addition, there is little data available on the social and institutional context of the market transactions, 
making it difficult to speculate on the decision-making patterns of the different actors involved. The role of 
social relationships of obligation, caste, familial ties, and other connections therefore needs to be considered, 
as do decisions regarding personal health care and local uses of plants which also affect decision-making 
patterns. 
Given that the private agents sometimes enter into advance contracts with the wholesalers, there is a 
distinct possibility that these agents may provide credit to petty traders, who in turn provide it to the villages 
or collectors: although this is a known practice in some cases, the overall extent to which it is done is not 
clear. In addition, little is known about the trading scenario of non-cash economies which still exist in large 
parts of India, especially in the Northeast Region. 
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The dearth of market information available to collectors and others located at a distance from the major 
urban markets also affects decision-making, while the lack of storage technologies and facilities is another 
major factor, which probably accelerates sales of plants even when prices may not be as competitive. 
33 Transformation Points of the Raw Materials 
Most significantly, all the case studies indicate that virtually no processing or value addition occurs in 
the marketing channels prior to purchase by the wholesale dealers. The few exceptions to this involve only 
the most basic processing of the products (Edwards 1993; Chandan, pers. comm., 1996). 
The following descriptions of the processing methods involved for three spices-tikhur (Curcuma 
angustifolia), baibirang (Embelia tsjer/am), and safed mush (Chiorophytum tuberosum), collected from the 
forests of Madhya Pradesh, provide examples of cases where minor transformation of the raw materials is 
necessary. After collection, ba/b/rang is sun-dried; safed mush is washed to remove the outer cover; and 
tikhur is grated/cut into small pieces and then rubbed by hand and left to soak overnight in water. In the 
morning, after the tikhur has been thoroughly soaked, the starch that has settled in the buckets of water is 
removed and formed into cakes. With the exception of tikhur, these plants require very little additional labor to 
prepare them for the market. 
In general, there appear to be few if any processing or quality requirements in the major Indian markets; 
wholesale agents buy maximum quantities of all specimens, and pay according to weight, regardless of 
quality. Even basic grading and cleaning operations tend to be centralized in major Indian cities (Edwards 
1993). 
34 Marketing Margins 
It is a commonly held view among those associated with the medicinal plants sector that the marketing 
of medicinal plants--like other NTFPs and many agricultural products in developing countries--is generally 
biased in favor of the so-called middleman,' resulting in low returns to the stewards and collectors of the 
resource. In many cases, prices paid by wholesalers are of a higher magnitude than the selling prices for 
collectors, even though no value addition to the plants occurs during the stages falling between the collector 
and the wholesaler. 
Table 3.1, reveals the prices of some important medicinal plants collected in Madhya Pradesh. Of 
particular significance is the remarkable disparity in the prices within the state and in Delhi, which in addition 
to Kanpur, Lucknow and Mumbai, is one of the major trading centres to which the medicinal plants of Madhya 
Pradesh are transported. 
Studies which document these price differences, usually posit the view that the middleman exploits the 
lack of market information to obtain a cheap price. Certainly this is at least partly true: the market is imperfect 
in terms of price-setting because of the restricted flow of information. However, the question of who benefits 
from this situation is more difficult to answer, requiring careful study of each transaction. In addition, such 
studies must also do away with the hypothesis of the 'middleman,' and instead recognize that there are 
several middlemen, including petty traders, contractors, and wholesale buyers, each of whom operates ac- 
cording to the different levels of information available to him. 
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Table 3.1 Prices of Important Medicinal Plants in Madhya Pradesh and 
Delhi Markets (All figures in Rs/kg) 
Species Local Name Katni Price Jabalpur Price Delhi Price 
Ernb//ca off/c/na//s Aonia 800 140 600 
Term ina/i be/erica Bahera 90 200 250 
Ch/orophyturntuberosum Safed mush, Kulai 14,000 25,000 20,000 
Curcumaarigustifolla Tikhur 2,000 — -- 
Embe//atsjer/am Baybirang 800 — 1,800 
Acorus ca/amus Bach 1,200 900 -- 
D/oscorea daeniona Baichandi 1,100 — -- 
Semecarpus anacard/um Bhilwa 100 1 QO 500 
Cyperus rotundus Nagamotha, Mutha 200 900 — 
Swert/a cf/ray/ta Chirayata 400 500 -- 
Woodfordiá flonbunda Dhawi phool, Dhua 200 — 700 
Aeg/ernarme/os Belguda 225 — 500 
RauwoIfi serpent/na Sarpgandha -- 2500 6000 
Source: Prasad and Bhatnagar (1991) 
While research on this question is lacking in India. it has been carried out in Nepal, which effectively 
serves as an Indian supply zone for medicinal plants, and helps to give some indication of the marketing 
channels leading to Indian markets. 
Table 3.2 Average Marketing Margins for main MAP species from 
Gorkha District, Central Nepal* 
Collectors Road Head Traders Terai WholesaIeJ 
Species Net Margin Gross Margin Net Margin Gross Margin Net Margin 
Jatamansi 50.02 9.04 -8.72 40.94 25.55 
Kutki 37.99 6.45 0.19 55.56 48.67 
Chiayata 52.21 16.45 2.17 31.34 12.57 
All figures represent percentages of Delhi wholesale prices during the main trading season (October 94- 
March 95) 
Source: Olsen Smith (1996) 
Table 3.2 shows the marketing margins for jatamans kutki, and ch/ayata harvested from the Gorkha 
district of West Nepal. In this situation, margins of the final Delhi prices obtained by two categories of 
middlemen - the roadhead trader, who is responsible for transporting the plants from the collector to the 
roadhead market; and the border town-based (Tarai) wholesalers, who moved the plants from the roadhead to 
the Delhi market - were analyzed. 
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As shown in the table, collector prices for the plants were relatively high, and accounted for 40 to 50 
percent of the prices paid by wholesalers in Delhi. At first glance, the gross margins (ranging from 6.45 
percent to 16.45 percent) accruing to the road-head traders also appear to be relatively fair, given that these 
traders do not add any value to the raw materials. However, when considered against the costs borne by the 
roadhead traders--including storage, transport, royalties, and rent-seeking by local officials, their margins of 
the Delhi prices are extremely low. Net margins range from a high of 2.17 percent down to even negative 
losses. 
By contrast, the gross and net margins of the Terai wholesalers, who alone are in contact with the Delhi- 
based traders, are exceedingly high, with net margins of up to 48.47 percent. 
This study highlights two major points. Firstly, it is evident that not all middlemen are equal, in terms of 
knowledge of the market, and secondly, traders in closest proximity to the collectors make the least profit, a 
conclusion also borne out by an ongoing study being conducted in Himachal Pradesh (Chandan, pers. comm. 
1996), This may be as important trend which needs to be given recognition. 
35 Overall Trends in Pricing 
Given the imperfections and complexities of the market as described above, price behavior is difficult to 
assess. Prices tend to be volatile and in some cases may follow 6 to 9 year cycles based on fluctuations 
between scarcity and over-supply, as well as seasonal variations. In addition, as noted above, prices also 
vary enormously in different places, a phenomenon which though still not fully understood, seems to be 
primarily a result of the general lack of information dissemination and overall awareness of different buyers 
and sellers at different points in the chain. 
Despite the variations in time and space, and the lack of extensive information, there is a reasonable 
body of evidence available from micro-studies to suggest that medicinal plant prices are showing an overall, 
rise at a relatively fast rate. In some cases, this has been linked directly with the growing scarcity in supply 
of several commercially valuable species. Some examples of these trends are given below. 
In Madhya Pradesh, a study of the price behavior for twenty medicinal plant species revealed that 
the rates of most species had shown a considerable increase in the last decade. The sharpest 
increase in price was reported for Baibirangdue to a scarce supply of the plant and a high demand for 
it. 
In Karnataka, a study conducted to observe the trend in rural prices demonstrated an increase in 
price for the majority of the 30 selected medicinal plants (Chandrakanth and Lokamanya 1994). In 
fact, 75 percent of the medicinal plants showed a positive rate of increase, ranging from 0.18 per 
cent for the bark of Ailarithus excelsato about 30 percent for the roots of Stereospermum suaveoleris. 
Prices varied according to the end use of the marketed plant part: the gum from roots of trees were 
more highly priced than the bark. 
In Kerala, prices were monitored at raw drug shops/stands in Thiruvananthapuram district over the 
period 1990-1995. In these 5 years, almost all of the 155 plants recorded, demonstrated a very 
significant increase in price; in several cases, as shown in Table 3.3, the 1995 prices of these plants 
were in excess of 200% of the 1990 price, and the prices of some had even quadrupled (Santhosh 
1996). 
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The Marketing Channels: From Harvest to Market 
Cooperatives for minor forest products have been established in several states of India, generally work- 
ing with tribals, who in many instances have been granted monopoly rights on the collecting of minor forest 
produce, of which medicinal plants are a significant part. Some of the most noteworthy cooperative organiza- 
tions currently dealing with medicinal plants are: the Girijan Service Cooperative society(GSCS); the Tribal 
Development Cooperative Corporation, and at the state level, Forest Development Corporations, and Minor 
Forest Produce Divisions. In addition, there are several other state-level federations or cooperatives. 
The national government also created TRIFED, the Tribal Federation, through the Multi-State Coopera- 
tive Act, 1984, which attempts to link these cooperatives for the benefit of the tribes involved in collection of 
MFP. In addition to facilitating communication and cooperation between the cooperatives, TRIFED is also 
developing a Marketing Information System. 
Case Studies 
In Kerala, the Girijan Service Cooperative Society (GSCS) is responsible for managing over 120 NTFPs 
which include medicinal herbs, spices, oils, seeds, dyes and edible products collected from the forest hills of 
Kerala. In fact nearly 61% of all NTFPs collected in the state were by GSCS cooperatives, of which there are 
33 in total. However, assessments by the GSCS suggest that nearly 70% of these cooperatives currently 
marketing NTFPs are functioning poorly if at all (Thomas and Meerabai 1993). 
A comparison of the prices of NTFPs marketed through private traders and the Scheduled Caste/Sched- 
uled Tribe (SC/ST) Federation showed that private traders invariably offered higher prices than the SC/ST 
Federation. In addition, private traders were willing to purchase several items not purchased by GSCS, which 
confined its purchases to a small group of tha well-known commercially valuable species. Also, the SC/ST 
Federation's poor record of timely payment to GSCS prevented them from collecting NTFPs on schedule, 
creating ample opportunities for private traders without similar monetary constraints. 
Due to the failure of the GSCS to provide competitive prices, tribals in Kerala are now said to sell their 
materials to middlemen, and at times directly to raw drug shops or herbal drug production units/agents. One 
study conducted in the Thiruvananthapuram district of Kerala in 1995 found significant differences between 
the buying prices of government-supported cooperatives and private raw drug shops. The researchers involved 
cite one case of the plant Adhatoda vas/ca, a relatively rare plant used in ayurvedic formulations, which was 
priced at Rs. 1 .4/kg by the tribal co-operative society; and Rs. 13.7/kg by the raw drug shop, a difference of 
nearly 900% (Santhosh 1996). Table 3.4 shows a number of other plants which are also subject to significant 
price variation. 
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Table 3.4 Variation of Prices in Medicinal Plants in Trivandrum District 
Between Raw Drug Shops and Tribal Cooperative Society (1995) 
(All prices in Rs/kg) 
Botanical Name Co-Op. Raw Drug Percentage 
Price Shop Price Variation 
Adathodavasica 1.40 13.75 882% 
EcIiota a/ba 1.00 8.67 767% 
Terrr,/naliachebufa 3.80 15.71 313% 
Syzygluincum/ni 1.40 16.67 1091% 
Tragia/avo/ucrata 4.75 29.88 529% 
Cyperus rotundiis 1.90 12.75 571% 
Cleroderidrum serratum 1.90 28.00 1374% 
He/icteresisora 1.15 10.50 813% 
Motnordica d/oica 3.3 37.67 1 042% 
Phy/lanthusainarus 1 18.57 1757% 
Source: Santhosh (1996) 
Given this situation, it is not surprising that in general where cooperatives exist, about 27 to 33 percent 
of the total produce is still marketed through private channels (Bhatnagar and Bisen 1996). 
A case study in the Central Himalayas also illustrates some of the difficulties faced by cooperatives. A 
marketing federation was established for the Khaljhuni medicinal plant collectors to protect their economic 
interests. This government cooperative aimed to help prevent exploitation in distant markets, and, on behalf of 
the government, to ensure that taxes were collected from the commerical sale of the medicinal plant products. 
As in Kerala, the cooperatives were limited in the range of products they could purchase, constraining 
the villagers' potential trade. In addition, cooperatives would only purchase the product at the motorable road 
head, incurring nearly twice the transportation cost of pick-up from the village.The maintenance costs of the 
cooperative were also quite high and this prevented them from pricing products as competitively as private 
traders, e.g., cooperatives would purchase P/crorrhiza kurrooa at Rs. 22.25/kg and lichens at Rs. 10.55/kg 
(1993), while traders would offer Rs 56/kg and Rs 26/kg, respectively, for the same products. The coopera- 
tives were also devoid of village representation which prevented any strong affiliations from developing (Rao 






The International Market 
While all the studies regarding the international market consulted for this report (Handa 1992; Patnaik 
1994; Shiva 1994; Raju 1995; APEDA 1996; Bisen 1996; CHEMEXCIL 1996; Lambert 1996; Tewari 1996) 
share certain limitations, the range of available information provides a sense of the scope and size of the 
export market. The available studies agree on two basic facts: firstly, that India figures prominently at the 
global level; and secondly, that in terms of both volumes and prices, it is showing accelerating annual rates of 
export growth. 
One summary of the medicinal plant export market suggests that exports from India have been steadily 
growing at the rate of 26 percent since 1991-92, with total exports rising to Rs. 1.65 billion, or approximately 
US$ 47 million in 1994-95 (Raju 1995). However, there figures would appear to be an underestimate if com- 
pared with information provided by the Centre for Minor Forest Products (COMFORPTS), Dehra Dun as shown 
below. 
Table 4.1 Medicinal Plants Export Values from 1960-61 to 1990-91 
all figures in Rs. million 
Period 
1960-61 1970-71 1980-81 1990-91 
Value 9.90 84.60 674.20 7675.0 
Source: Shiva (1994) 
According to COMFORPTS, medicinal plant exports reached a value of over US$ 260 million by 
1990-9 1. 
4.1 Detailed Studies Concerning the 
Export of Medicinal Plants 
Less comprehensive studies focusing on a particular aspect of this sector, or on particular plants, 
suggest that the total official market for exports lies somewhere in between the two estimates presented 
above. One such study has been conducted by CHEMEXCIL, the Basic Chemicals, Pharmaceuticals, and 
Cosmetics Export Council, a GOl-constituted group comprised of trade, government, and industry representa- 
tives (Lambert et al. 1996). 
As indicated in Table 4.2, according to CHEMEXCIL, exports of crude drugs and essential oils from India 
from the companies under study constituted a market of nearly half a billion dollars in the past decade. In 
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1994-95 alone, exports of crude drugs exceeded US$53 million, representing an 18 percent growth rate over 
the previous year, and almost a trebling of the market size as compared to 1984-85. 
Table 4.2 Export of Crude Drugs and Essential Oils from India Between 1985-1995 
(All figures in US$ '000) 
Year Crude Drugs EssenUal Oits Total Revenuel 
1985-86 19,272 4,553 23,825 
1986-87 16,848 6,889 23,737 
1987-88 22,489 4,638 27,127 
1988-89 17,805 4,974 22,779 
1989-90 25,504 8,600 34,104 
1990-91 36,802 5,821 42,623 
1991-92 41,345 15,592 56,937 
1992-93 48,417 15,267 63,684 




Source: CHEMEXCIL, cited in Lambert (1996) 
However, as recognized by the organization itself, CHEMEXCIL's membership represents a relatively 
small segment of the industry-mainly the larger companies. The estimate of US$53 million neither takes into 
account the role of small enterprises, nor that of the informal/illegal market, thus reinforcing the generally held 
conviction among experts interviewed that the total official market is significantly larger than indicated in 
many of the available statistics. 
Keeping track of exports of medicinal and aromatic plants is officially the responsibility of the Agricul- 
tural and Processed Food Products Export Development Authority (APEDA). APEDA uses the Indian Trade 
Classification Code based on the harmonized system (ITC-HS), which is in conformity with the two most 
widely followed global classification systems, the Brussels Tariff Nomenclature and the Standard International 
Trade Classification (SITC) of the United Nations (Patnaik 1994). The Directorate General of Commercial 
Intelligence and Statistics (DGCIS) in Calcutta publishes a volume containing the official trade statistics of all 
11,000 commodities categorized under this system. 
Medicinal plants fall under the designation code 12.11, which is defined as "Plants and parts of plants 
(including seeds and fruits), of a kind used primarily in perfumery, in pharmacy, or for insecticidal, fungicidal, 
or similar purposes, fresh or dried, whether or not cut, crushed, or powdered." 
The 36 groups of medicinal plants falling within this category are not defined by species per Se. Instead, 
they are defined as groups such as 'ginseng roots,' or by local and trade names such as Chiraita. It should 
also be noted that these groups do not account for all the plants, which are known to circulate in the interna- 
tional market. Nevertheless, this information which is regularly published every fiscal year, provides strong 
indications of some of the major contours of the market. 
The ten most-exported items in terms both of weight and dollar value are listed in Table 4.3, along with 
their export values over the period studied. 
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Table 4.3 Reported Sale Values of the Top Ten Medicinal Plant Exports, 1990-94 
(All figures in As. Millions) 
* Includes all roots apart from those of liquorice, belladonna, cubebs, galaragal, ipecac, serpentina, 
zedovary, and kuth. 
Source: APEDA (1995) 
While several of the products described above have annual markets worth a sum in the region of USD 1 
million, a product of particular interest is lsabgol (Psyllium husks), which in 1994 brought in sales of over one 
billion Rupees, or approximately USD 30 million. Another important aspect of these statistics concerns the 
significant variations which occur from one year to the next in terms of volumes of trade. Although it is 
impossible to ascertain the reasons for such fluctuations from the data presented above, nevertheless, their 
scale and frequency suggest that the market for medicinal plants is still very much at the embryonic stage. 
Some of the importing countries are very constant in their demands for plant materials and by far, the 
most frequent destinations for exports of medicinal plants are the USA, Japan and Germany, followed by other 
European countries and the Middle East. India's top ten medicinal plant trading partners are listed in 
Table 4.4. 
Trade with bordering South Asian countries is also high, and is in fact probably much higher than be- 
lieved since the informal sector dominates a large part of the trade with countries such as Nepal and Bangladesh 
(Edwards 1993). 
In addition to being a seller in the international market for medicinal plants, India is also buyer, especially 
from its neighbors, though often on an illegal informal basis as mentioned earlier. APEDA statistics for the 
period 1990-95 reveal that the major countries reporting sales to India are Pakistan, Nepal, and Singapore, and 
that the greatest volumes of imports are for liquorice roots, poppy, and Ayurvedic/Unani herbs. 
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Psyllium Husk 581.0 620.0 — 692.0 1,060.0 
Psyllium Seed 56.9 65.2 56.7 62.9 77.1 
Sandalwood Chips/Dust 310.0 247.0 183.0 156.0 92.4 
Senna Leaves and Pods 37.3 112.0 122.0 82.0 85.1 
Tukmaria 2.96 — 2.47 2.22 18.9 
Ayurvedic/ Unani Herbs 35.2 56.2 99.4 85.3 99.8 
Other Roots* 75.3 58.7 83.8 77.5 13.2 
Other Herbs* 45.8 103.0 145.0 102.0 75.4 
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Table 4.4 Top Ten Export Destinations for Indian Medicinal Plants, 1990-94 
(All figures in As millions) 
Country 1990 1991 1992 1993 1994 
Bangladesh 11.7 15.5 21.0 8.72 2.07 
China/Taiwan 69.4 131 9.66 105 54.5 
France 50.9 53.5 58.7 55.6 55.5 
Germany 90.7 124 127 88.7 130 
Italy 16.0 16.4 29.8 22.2 32.6 
Japan 48.4 49.3 36.8 36.9 30.0 
Pakistan 36.3 28.9 45.9 51.6 31.9 
Saudi Arabia 18.2 34.0 330 150 11.4 
U A E 15.1 22.1 17.9 14.8 22.7 
U K . 73.7 54.9 87.6 80.9 97.0 
USA 49.7 548 683 600 653 
Source: APEDA (1995) 
Tflie Policy Enviro...mn.ient 
The Customs Act of 1986, now in force through the Export/Import Policy (or EXIM policy) of 1992-97, is 
the primary regulatory policy relating to export of medicinal plants. The EXIM policy restricts the export of 
three major plant groups: 
Species listed in the Appendices of CITES, the Convention on International Trade in Endangered 
Species, to which India is a signatory; 
Wild orchids; and 
45 additional items of plants, plant portions, and their derivatives indicated in Public Notice No. 47 
dated March 30, 1994. 
Medicinal plants have only recently begun to figure prominently in the Convention on International 
Trade in Endangered Species, or CITES and this is largely because of strong interest expressed by India in 
November 1994 (Schippman 1996). India proposed 13 medicinal plant species for inclusion in the CITES 
Appendices, of which 3 were accepted. Currently, the total number of species regulated by the Convention is 
9, as listed below. This number is however still considered to be very small compared to the number of plants 
for which regulation through the Convention would be appropriate. Nevertheless, it represents a significant 
increase given the fact that only one medicinal species, .5aussurea lappa, was originally covered by the 
Convention. 
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Table 4.5 Medicinal Plants Regulated by CITES Convention 




D/oscorea de/toidea Psingli mingli 
Panaxqu/nquefol/a American Ginseng 
Podophyllum hexandrum Papra / Vakasa 
Prunus africana Bankakji 
Pterocarpus santa//ntis 
* Kino / Raktachandan 
Rauwo/fia serpent/na Sarpgandha / Serpentwood 
Saussurea/appa Kut, Pachaka 
Taxus wal//chiana * Yew 
* 
Proposed by India in the CITES November 1994 meeting. 
Source: Schipmann 1996 
Confusion regarding the export status of pharmaceutical products composed of Saussurea and Aloe in 
April 1994, was clarified by CITES provisions, since according to Resolution Conf. 5.9, not only living plants, 
but also cosmetics and other pharmaceuticals prepared from living plants are regulated (Nambiar, pers. comm., 
1996). This means that these products, as well as the plants themselves, would require export permits from 
their countries of origin before they could be traded in the international market. 
There is, however, some concern among the international scientific community, that the actual imple- 
mentation of CITES regulations and the requirement of export permits from the countries of origin is not being 
fulfilled with regard to medicinal plants (Schippman 1996). The primary reason for this relates to the lack of 
well-educated customs officials at the points of export. Identification manuals have still not been prepared for 
the medicinal species listed in CITES, with the result that customs officials cannot distinguish between 
various plants, especially as medicinals are generally designated by their trade names (rather than botanical 
names) by the time they reach the international markets, and are traded as parts, rather than whole plants. 
The forest department staff issuing transit or export permits are largely untrained in the identification of 
species in such forms and the preparation of identification manuals is generally held to be the responsibility of 
the country which proposes a species for inclusion. India has yet to produce these manuals. 
In response to these concerns, the German Ministry of Environment is funding a study which will deter- 
mine trade volumes of the plants; identify which parts and derivatives are the major trade commodities (and 
therefore require comprehensive standards for identification); review problems of implementation; and make 
recommendations for improved implementation in the future (Schippman 1996). 
Since the issue of a Notice restricting the export of an additional 45 plant species, many of which are 
medicinal plants as well as species covered under CITES, it has become a government requirement to obtain 
a Certificate of Cultivation issued by a Regional Deputy Director (Wildlife), Chief Conservator of Forests or 
Divisional Forest Officers of the state from which the plants were procured, in order to export them. This notice 
further restricts exports to just six major ports: Mumbai, Calcutta, Cochin, Delhi, Chennal, and Tuticorn. 
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An additional export regulation of particular interest on the Indian medicinal plants front concerns the 
total ban--imposed in 1969--on the export of the roots of Rauwolfia serpent/na, locally known as sarpagandha 
(Lambert 1996). This species, known for its reserpine content, was banned in order to help develop a local 
extraction industry in India. Although reserpine can now be synthesized, the process remains expensive and 
extraction is still not an economically viable activity. This action, taken nearly three decades ago, and still in 
force, has not yet been implemented with respect to any other medicinal plant species in the country. Further, 







Domestic Drug Production 
Medicinal plants are the raw materials for indigenous drug manufacturers within India. These manufac- 
turers can be divided into two types of enterprises: those which produce drugs used in the so-called Indian 
Systems of Medicine and Homeopathy (ISM); and those which produce allopathic drugs. 
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of Medicine and Homeopathy (ISM) 
Unlike the folk and tribal systems of traditional medicine outlined in Chapter 2, the traditional systems of 
Ayurveda, Siddha, and Unani are well-documented, highly formalized systems, which have evolved over 
centuries. Ayurveda developed with the Aryan invasion (see Chapter 1). The origins of the Siddha system, 
whose practice is mostly confined to the south of India, particularly the state of Tamil Nadu, are however more 
contested. While some hold that the system is a variation of Ayurveda, others argue that it has pre-Aryan, 
Dravidian roots. The Unani system, as mentioned in Chapter 1, was a later introduction and continues to be 
widely practiced especially in North India and among the country's Muslim community. Homeopathic medi- 
cine is also often attached to the other three systems in describing India's medical diversity, and the policy 
and planning measures adopted by the government, officially recognize all four forms of medicine for the 
purposes of national health services. Although not a traditional system, homeopathy like these other systems 
differs in its theoretical orientation from allopathy, and is highly reliant on medicinal plants and nature-based 
cures. In addition to these four systems, Yoga, Naturopathy, and Amchi (Tibetan) medicine are also practiced 
in India, although the available databases and degrees of recognition accorded to these systems appear to be 
low at present. 
ISM in India command the same degree of scope, organization, and reach that is commonly associated 
with Western allopathic medicine in other countries. It has been estimated that there are approximately 
460,000 practitioners of the traditional systems, of whom about 271 000 are registered under the state boards, 
and about 145,000 practitioners of homeopathy (see Table 5.1). 
There are also over 100 undergraduate teaching institutions specializing in traditional systems of medi- 
cine and awarding degrees in Ayurveda, Siddha, and Unani, as well as over 20 postgraduate departments 
awarding degrees and doctorates. Of the registered practitioners estimated by the study mentioned above, 
117,774 Ayurveda; 10,268 Unani; and 1,559 Siddha were institutionally qualified (Bajaj and Williams 1995). 
Finally, traditional medicine hospitals account for 1,690 of the total number of hospitals in India, and 
there are at least 13,770 dispensaries of traditional (mostly plant-based) medicines (Bajaj pers. comm. 1996). 
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Table 5.1 Numbers of Practitioners of Indian Systems of Medicine 




Ayurveda (Registered) 223 000 117 774 
Siddha (Registered) 18,128 10,268 
Unani (Registered) 30,456 1,559 
Unreglstered* 189 416 — 
Total 460 000 30456 
* Estimate. Source: Bajaj and Williams (1995) 
Size of the Industry 
According to the Office of the Drug Controller General of India, there were 7843 licensed pharmacies 
manufacturing drugs used in the ISM, and 857 licensed pharmacies manufacturing homeopathic medicines in 
1991. The largest numbers of these pharmacies are located in the states of Uttar Pradesh, Kerala, Maharashtra, 
and Gujarat, while the lowest (and sometimes nil) numbers occur in the states of the Northeast region of the 
country. 
In addition to approximately 8000 of these licensed pharmacies, it is also well known that a number of 
other small-scale processing enterprises are unlicensed and operate in the informal sector (Ahmed 1993). 
Unfortunately, data regarding the participation of both the licensed and unlicensed firms in the medicinal plants 
raw materials trade, and the extent of their demands for raw materials, are not readily available. Further, the 
structural breakdown of the licensed pharmacies in terms of large and small companies is unknown, making 
it difficult to assess the level of concentration in the market. Similarly, the size of the market for processed 
drugs, both domestic and international, is unknown, and though private research is known to have been 
conducted by many of the larger companies (Madhusudan pers. comm., 1996), in the face of these informa- 
tion gaps, which require extensive primary research, only a few case studies and examples can help to 
provide an indication of the current character of the industry. 
Some of the most interesting statistics have been provided by the Arya Vaidya Sala, Kerala, which 
manufactures traditional ayurvedic drugs for domestic use as well as for limited export. The Sala has pro- 
vided detailed information with regard to plants used, people employed, and values of processed products 
(Table 5.2). 
The relatively large numbers of people, plants, and products involved suggest that the domestic industry's 
consumption of medicinal plants must indeed dwarf that of the formal exports market, especially as the Arya 
Vaidya Sala is only one of 8,000 manufacturers involved in the sector and represents neither the largest nor 
smallest among these. 
Growth has also occurred in this sector with one of the largest ayurvedic companies, Dabur India Ltd 
reporting annual growth rates of 25 percent in their sales since 1990, and a doubling of their turnover every 
three years. (Aryal 1993). 
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Table 5.2 Resource Use Patterns, Income, and Employment Generation 
Reported by Arya Vaidya Sala, Kottakal, Kerala 
Plants "imported from northern states" 
Number 550 
Amount 500 tons (dry weight) 
Roots/rhizomes 25% 
Origin Calcutta, Orissa, Assam, Maharashtra, Delhi, 
Madhya Pradesh, Punjab, and Kashmir 
Market Value Ca. As 5.2 crore (US$ 1.6 million) 
Collecting/Transport Cost 2-3% 
Plants cultivated in Kerala 
Number 150 
Amount 400 tons 
Roots/Rhizomes 40% 
Market Value Ca. Rs 4 crore (US$ 1.35 million) 
Number of People Employed 1600 
Income Generated Rs 6 crore 
Medicinal Plant Processing in Kerala 
Number of People Employed 540 
Sales Values Ca. As 8 crore (US$ 2.65 million) 
Annual Storage 540 tons 
Estimated Loss in Storage 0.25 tons 
Finally, estimates made by traders in Guwahati suggest that the annual turnover of the pharmaceutical 
concerns in Assam, where only 18 licensed companies are known to be in operation, could be 'anything 
between Rs. 350 to 450 crores," requiring supplies of more than 700 metric tons of high-value medicinal plants 
in the region every year (Subhani 1994). 
Although no large-scale studies have been conducted, some data has been collected at the micro-level 
which bears this out. To take one example, a recent study of ayurvedic products in both the organized and 
unorganized marketing channels from 1987-1990 revealed an increase in trade of nearly 30 percent (Nambiar 
pers. comm., 1996). 
Links to Primary Health Care 
Through the Five-Year Plans of the government, some attempts have been made to develop ISM as a 
main component of Primary Health Care (PHC). In addition, the 1982 Health Policy served to integrate the 
practitioners of traditional medical systems into the nation's health care system. Thus, for example, primary 
health care centers and dispensaries are now permitted in most states to have a traditional practitioner in 
addition to the two required allopathic physicians (Bannerman 1982). 
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5.2 The Allopathic Industry 
Although less involved generally in the utilization of medicinal plants, the allopathic pharmaceutical 
industry in India also needs to be understood in order to provide a comprehensive picture of the current 
scenario, as well as insights for developing more effective options when dealing with the traditional drugs 
industry. 
According to the Drug Controller of India, the allopathic industry has seen significant growth in the past 
few decades, thanks largely to a supportive politico-economic context. Industrial policies have in general 
favored indigenous growth while import policies restricting the import of drugs which are indigenously pro- 
duced, along with customs tariff barriers, have served to protect local industry from international competition 
in the domestic market (Gupta 1995). 
Nevertheless, the role of India's allopathic industries is mostly confined to the production of bulk drugs 
for mass consumption. The domestic companies cannot compete internationally, as they are constrained by 
outdated technologies, a limited production capacity, and high raw material/solvent costs. This last con- 
straint is especially noteworthy as the prices of commonly used chemicals are 3 to 6 times higher then their 
international counterparts (Gupta 1995). 
The export of a few of the bulk drugs produced in India is mainly possible because the companies 
involved import the materials they need duty free, and because the countries buying these products do not 
produce them locally as a result of the safety hazards and/or environmental degradation associated with their 
production. 
5.3 The Policy Environment 
Although affected by a large number of policies at the government level, the two most critical policy 
domains for indigenous industry are those regarding intellectual property rights, and standards and quality 
controls. 
Intellectual Property Rights 
As mentioned in Chapter 2, India has recently accepted Trade Regulated Intellectual Property (TRIPS) 
as a part of the General Agreement on Trade and Tariffs (GATT). This agreement may have a significant 
impact on the country's drug manufacturing industry, as it stipulates the adoption of several minimum stan- 
dards by member countries. With regard to India's compliance with these standards, a major debate is under- 
way within the country. 
The most significant aspect of TRIPS for the industry is its requirement that patents be provided for 
inventions in all fields of technology. The minimum term of patenting is 20 years from the date of filing (The 
Crucible Group 1994). Further, it is generally felt that patents should cover products, and not simply pro- 
cesses, in order to provide more effective protection for rights-holders. 
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India's present system, based on the Patent Act of 1970, essentially defines process patents. However, 
the implications of developing product patents could involve higher investments in research and development 
by the traditional industry, given the likely returns though patent protection. This might then result in the 
availability of new drugs for primary health care, as well as improvements in quality and production standards 
for existing drugs. Furthermore, it might have a relaxing effect on the secretive and defensive nature of the 
trade. 
Enforcement of such patents is however difficult in a country with such large informal markets. Cheap 
and often adulterated imitations are already known to abound in the marketplace. Few companies have the 
resources which would be necessary either to ensure through legal action that their patents are secure, or to 
undertake massive and effective advertising campaigns which would create a niche for their own brands of 
innovative products. Hence the change to a product patent system might have less impact than in developed 
countries. 
In addition, although companies might be inclined to invest more in research and new product develop- 
ment, the monopoly guaranteed to them by a product patent regime may encourage higher prices, such that 
access to the product would be difficult for poor consumers. Furthermore, if a market was developed for such 
new products among the upper and upper-middle classes, companies might begin to divert resources towards 
production of these more profitable products, and away from the low profit-margin products purchased by the 
poor. 
Of all these issues, the major dilemma confronting India is how to apply patent law to formulations and 
products which have been developed over thousands of years. In a sense, no one can claim innovation' of 
the medicines of the ISM. Yet, it is also argued that upgrading a simple production technology to a more 
sophisticated one, or adding or subtracting a single ingredient, does constitute an innovation of sorts. In 
addition, awarding rights to a single company or individual, when entire communities of practitioners have 
been involved, is also a difficult proposition-few would claim that it is fair for a private company to benefit 
exclusively from knowledge that was generated in the public domain. At the same time, the government is 
facing pressure to encourage this very situation as foreign companies already have access to patenting, and 
many fear that India's wealth of traditional knowledge may be damaged by these interests if the government 
does not act quickly to protect this knowledge. 
Quality Controls/Standards 
Quality control and standards constitute another area where policy making is still a work in progress.' 
The Drugs and Cosmetics Act, 1940, was amended in 1964 to include Ayurveda, Unani and Siddha, and 
provides for a limited set of controls over the production and sale of traditional medicines. The provisions 
include the following: 
- Manufacturing should be carried out under prescribed hygienic conditions, and also under the super 
vision of a person having the prescribed qualifications 
- The raw materials used in the prearation of drugs should be genuine and properly identified 
- The formula or the accurate list of all the ingredients contained in the drugs, should be displayed on 
the label of every container 
One difficulty in implementing the Act was dueto this fact that specific sets of standards were lacking 
for the preparation of these traditional medicines. To fill this void, the Pharmacopoeial Laboratory for Indian 
Medicine (PLIM) was created in Ghaziabad by the Ministry of Health and Family Welfare (Department of 
Health). PLIM houses the Drug Standardization and Testing Unit, the Drug Depot, and the Herbarium and 
Reference Museum. Pharmacopoeias are also now available for each of the major ISM. 
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Nevertheless, a universally recognized set of quality control standards has still not been developed for 
the preparation of ISM drugs, which pose serious challenges as they often contain a number of constituent 
plants, unlike the single principle allopathic medicines. Quality standards and guidelines would by necessity 
differ from those for allopathic drugs, as the means of production for each type of drug is different. Some of 
the unique aspects of traditional medicine preparation that would need to be considered include specific 
means of identifying and collecting constituent plants, including seasons for collections and appropriate ages 
of plants; ecological origins; cleanliness in processing; and adherence to documented procedures in the 
ancient texts of relevance (Bajaj and Williams 1995). 
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Interventions to date have been of three kinds: encouraging research and development; promoting tradi- 
tional medicine; and developing partnerships among the ISM private sector. 
The Government has recently recognized that with the signing of GATT and the reduction of the entailed 
protectionist measures, the allopathic drugs industry is very likely to suffer. It has been predicted by the Drug 
Controller General of India that by the time trade ceilings are reduced to the agreed ceiling of 25 percent in the 
year 2000. most bulk drugs produced in India will have been priced out of the market by imports. 
In an attempt to give a greater edge to the indigenous industry, several incentives have been developed 
to encourage research and development in the private sector, and to improve its chances of being internation- 
ally competitive. These include (Gupta 1995): 
- 100% income tax deduction of R & D expenditure from profits; 
- Accelerated depreciation allowance at 40% instead of 25% if a plant is making goods based on 
indigenous technology; 
- Exemption from price control for bulk drugs based on indigenous technology; and 
- Weighted tax deduction at 125% for sponsored research in approved national laboratories. 
As in most fields in India, research in traditional medicine continues to be largely the province of public 
sector institutions. The major national bodies for the Indian Systems of Medicine and Homeopathy are the 
Central Councils for Research, all based in New Delhi-one in Ayurveda and Siddha (CCRAS); one in Unaril 
Medicine (CCRUM); one in Homeopathy (CCRHY); and one in Yoga and Naturopathy (CCRYN). 
In addition, a Working Group on Indian Systems of Medicine and Homeopathy was recently set up by the 
government, bringing together policy makers from the various ministries and departments dealing with tradi- 
tional medicine and medicinal plants. This Group was convened to make recommendations for the Ninth Five 
Year Plan, which started in 1997. The Group has proposed an investment of As. 18.4 billion (approximately 
USD 525 million) for a broad range of activities designed to provide support to the sector, as itemized in 
Table 5.3. 
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Table 5.3 Recommended Ninth Five Year Plan Budget for Indian Systems of Medicine 
and Homeopathy Developed by the Working Group on ISM&H 
(all figures in Rs. 10 million) 
Effective Use of ISM&H for Health for AtI 50 
ISM&H Treatment Facilities at Block Level 110 
Covering 25% of All Blocks 
ISM&H Facilities at the Central Government 50 
Health Scheme (Branches in Dispensaries) 
Support for NGOs and Government Hospitals 100 
Upgrading of Facilities and Standards for 225 
Undergraduate/Postgraduate Studies 
Medicinal Plants and Herbs 125 
Development/Germplasm Banks/Agrotechniques 
Research and Development in }SMH 350 
Professional Upgrading Program 50 
Strengthening of Institutions, Building Centres 100 
of Excellence 
Strengthening of Laboratories 50 
Strengthening of Government Pharmacies 20 
Other 610 
CCRUM (1996) 
Another major intervention necessary to promote the Ayurvedic system concerns the development of a 
detailed pharmacopoeia. This task, began in 1962, and by 1986, the Ministry of Health and Family Welfare 
presented the Ayurvedic Pharmacopoeia of Lndia, Volume 1, Part 1, with subsequent volumes being published 
as further experimental data becomes available (Dhanoa 1986). 
At the international level, the Global Initiative for Traditional Systems of Health, (GIFTS), an NGO 
committed to the perpetuation of traditional medical systems, sponsored regional workshops in Asia, Africa 
and Latin America which culminated in an international meeting held in the UK in 1995. India was a major 
participant during these conferences due to the emphasis placed on the Indian Systems of Medicine. A 
common theme throughout all the conferences was the need for clearly defined policies promoting the safe 
utilization of traditional medicine, and the need to strengthen these systems-in order to ensure that they 
continue to provide health care to the millions who depend on them. 
National interests are linked to those of the World Health Organization through the Gujarat Ayurveda 
University, Jamnagar, which is a WHO centre for traditional systems of medicine. 
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Developing Partnerships among the ISM Private Sector 
Although the traditional drug processing and manufacturing companies are relatively unknown (with a 
few exceptions such as Zandu, Dhootapapeshwar, and the larger companies such as Indian Herbs and Dabur), 
conventional wisdom holds that these companies are the major culprits accounting for the rapid depletion of 
the resource base (Chapter 1); and for the continuing market inequities (Chapter 3). On the other hand, 
realizing that such practices are unsustainable in the long run for achieving profitable business, many of these 
companies have shown an interest in working together to address these problems. In many cases, too, the 
people engaged with these companies feel a strong sense of moral obligation regarding the resource base and 
people who harvest it. 
Many of the larger companies have already begun to form alliances, with the government and other 
agencies to address areas of mutual concern. CHEMEXCIL, the Basic Chemicals, Pharmaceuticals and 
Cosmetics Export Promotion Council, is one such example of this kind of trade association, which looks into 
issues in the medicinal plants sector. The Council recently published a monograph in 1992, Selected Medic!- 
na/Plants of/nd/a, which took up issues of identity, efficacy, safety and clinical usage of medicinal plants 
(Lambert 1996). Its also maintains trade statistics and supports the development of a conservation policy for 
medicinal plants. 
There are relatively fewer efforts underway to form partnerships with the smaller companies involved in 
the drug production sector, and it is difficult to gauge the significance of their participation in the absence of 
reliable statistics. However, an ongoing study sponsored by the IDRC Medicinal Plants Network is undertak- 
ing a major survey of these companies in India and elsewhere in order to begin to understand their role in the 
process, as well as to identify constraints and opportunities for their growth and success, and the potential for 
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Chapter 6 
Information and Coordination in the Sector 
The great diversity of the resource base, systems of medicine and actors involved in the medicinal 
plants sector makes the provision of reliable information as well as coordination a necessity for planning 
interventions. This chapter briefly examines the institutional base and the types of information currently 
available in India. 
61 Databases 
In December 1995, the Centre for International Forestry Research (CIFOR) organized a workshop on 
non-wood forest products databases, to assess current information resources. Among the databases ac- 
counted for in India, three covered medicinal plants, two of which were located at the Kerala Forest Research 
Institute (KFRI), and the Centre for Minor Forest Products (COMFORPTS), Dehra Dun, respectively and 
covered a wide variety of NTFPs, including medicinal plants. The databases at KFRI are primarily descriptive, 
while those at COMFORPTS include descriptive bibliographic information. 
Table 6.1 Institutions Participating in INMEDPLAN 
Institution Location Responsibility 
I 
Source: INMEDPLAN (1994) 
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In addition to the databases described above a large national database on medicinal plants is being 
developed by the INMEDPLAN initiative. This involves the participation of 9 nodal agencies responsible for 
the provision of different kinds of data based upon their own research and development activities (Table 6.1). 
The ultimate aim of INMEDPLAN is to offer an on-line, real-time accessible version of the data held at 
each institution. The organizations involved in the initiative have recognized that serious gaps exist in the 
data currently held, and that many thousands of records maintained require updating. Further, the non- 
availability of standard recording formats to facilitate the computerization of data has been a long standing 
problem. This is therefore being addressed by a series of meetings held since 1994, which have begun to 
identify such standards in each specialized field. 
Complementing these databases is one maintained by the IDRC Medicinal Plants Network, which con- 
tains a list of researchers and institutions working on various aspects of medicinal plants. 
6.2 Publications 
By far the most active force in medicinal plant publications is the Council of Scientific and Industrial 
Research (CSIR), chiefly through its Publication and Information Directorate (PID) in New Delhi. PID brings 
out one of the worlds foremost abstracting services on medicinal plants, the bimonthly Medicinal andAromat- 
ics Plants Abstract (MAPA), which scans some 600 journals published in 22 languages from 55 countries 
around the world. Each issue also includes information on recent patents filed and papers presented at 
international workshops, and is also available for on-line screening through MAPIS (Medicinal and Aromatic 
Plants Information Service). 
PID is associated with similar services throughout the world: the Japanese Information Centre for Sci- 
ence and Technology, Tokyo; Thailand National Development Centre; DSIR, Wellington, New Zealand; and 
the National Library for Agricultural Sciences, Bogor, Indonesia. The work on medicinal plants carried out by 
PID is also done in collaboration with the Indian Council of Medical Research (ICMR), the government-spon- 
sored Central Councils for Research in Ayurveda, Siddha, Unani, and Homeopathy, and INMEDPLAN. 
The Central Institute for Medicinal and Aromatic Plants (CIMAP), Lucknow, publishes a quarterly jour- 
nal, Current Research on Medicinal andAromat/c Plants (CROMAP), which includes reviews, abstracts, and 
marketing information, while The NGO, FRLHT, Bangalore, publishes a quarterly magazine Amruth, which 
focuses on issues of relevance to conservation of medicinal plants. 
6.3 International 
and Regional Networks 
Networks dealing with medicinal plants in which India is represented have been established by interna- 
tional organizations including the United Nations Educational, Scientific and Cultural Organization (UNESCO), 
the Food and Agriculture Organization (FAQ), and the International Development Research Centre (IDRC). 
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Asia-Pacific Information Network on Medicinal 
and Aromatic Plants (APINMAP) 
The APINMAP, network was established in 1987 by UNESCO, with the primary objective of collecting, 
collating, and disseminating information on research, production, processing, trade, and development among 
the participating countries. India has been represented in the network since its inception; other countries 
participating include Australia, China, Korea, Nepal, Pakistan, Papua New Guinea, Phillipines, Sri Lanka, 
Thailand, and Vietnam. APINMAP's primary focus is on the sharing of information between participating 
representatives. The Network organized a series of meetings which led to the drafting and endorsement of the 
Chiangmai Declaration, "Saving Lives by Saving Plants," a combined undertaking by experts in health care 
and plant conservation. This has helped to articulate the basic issues of conservation and the role of medici- 
nal plants in health care for all at a relatively early stage in terms of awareness of medicinal plants in the 
greater international community. APINMAP also plans to distribute directories of institutions and researchers 
in its member countries. 
Asian Network on Medicinal and Aromatic Plants (ANMAP) 
FAO supports and coordinates ANMAP, the Asian Network on Medicinal and Aromatic Plants, whose 
main objective is to assist member nations in developing their resource base of medicinal plant raw materials, 
whether through exchange of information, know-how, or germplasm. Countries represented in the network 
include China, India, Indonesia, Korea, Nepal, Pakistan, Philippines, Sri Lanka, Thailand, and Vietnam. ANMAP 
publishes a bimonthly newsletter, NANMAF and organizes Asian symposia on medicinal plants, spices, and 
other natural products. A symposium held in the Philippines in 1992, resulted in the Manila Declaration, which 
emphasizes the ethical responsibilities of those involved in the utilization of Asian biological resources and 
which was endorsed by 283 scientists from 31 countries. 
IDRC Medicinal Plants Network (IMPN) 
The IDRC Medicinal Plants Network (IMPN), which is headquartered in New Delhi, with a Secretariat 
operating out of IDRC's South Asia regional office; has an active portfolio of projects in the country. Other 
countries represented in IMPN include Bangladesh, Bhutan, Nepal, Pakistan, and Sri Lanka; active collabora- 
tors and advisers are based in Canada, the US, UK, and Sweden. In addition, IMPN is closely linked to 
networks on medicinal plants sponsored by IDRC in Latin America and Africa. 
IMPN's general objective is to provide the research and networking foundations required for developing 
medicinal plants in ways which benefit the health, environment and economies of the people of South Asia. In 
particular, it has targeted the well-being of women, the very poor, and tribal peoples. The Network's activities 
fall into three main categories: A Strategic Research Portfolio; A Country Studies Program; and Networking 
Services. 
The Strategic Research Portfolio has been organized in terms of three thematic areas identified as 
priorities during a meeting of regional experts in the disciplines of botany, anthropology, pharmacology, chem- 
istry, and forest products and forestry, held in Calicut in 1994. The priorityareas identified were Biodiversity 
Conservation; Marketing and Enterprise; and Health and Medicines. IMPN sponsors a range of researchers, 
NGOs, government agencies, and the private sector in each of these focus areas, the idea being to cover all 
aspects of the medicinal plants trade from production through to consumption. Projects are development-led, 
that is, research is oriented to provide tools and information which lead to successful development interven- 
tions. IMPN has recently been converted into an IDRC program called the Medicinal and Aromatic Plants 
Program in Asia (MAPPA). 
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Some major Indian institutions active in the Network include the M.S. Swaminathan Research Founda- 
tion, the Bharatiya Agri-Industries Foundation (BAIF), the Indian Institute of Science (II Sc.), the Vital Mallaya 
Scientific Research Foundation (V M S R F), and the Arya Vaidya Sala (A V S), Kottakal. 
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Medicinal Plants sector in India operates in policy and institutional vaccum. The sector faces a number 
of policy and legal constraints. 
71 Constraints, Opportunities 
and Targets 
Earlier chapters of this report have highlighted three overall constraints relating to the medicinal plants 
sector in India. These are: 
Depletion of the Resource Base, which is the foundation of the entire sector; 
Decline of Folk Traditional Medicine, a source of primary health care for an estimated five 
hundred million people in the country; and 
impoverishment of Rural People, who are the stewards of the resource and the holders of 
traditional ecological and medical knowledge, through inequitable marketing channels. 
The report has also identified three major opportunities in this sector: 
India's Comparative Advantage and her Potential to Play a Leading Role in the 
International Market, as a result of the growing importance of Indian exports in providing a 
source of revenue for the country; 
The Existence of a Strong Classical Traditional Medicine Sector with Developed 
Industrial and User Bases, which employs millions and provides for the health care needs of 
hundreds of millions of peoples. 
A Growing Information Resource Bases, which can be built upon through collaborative 
efforts, and which links India to the international scientific community. 
The constraints and opportunities described above are closely related. Any initiative directed at one is 
very likely to have on impact on the others. It is thus essential that these issues should remain at the 
forefront, from the planning stage onwards, when considering new interventions for the sector, as well as when 
assessing the potential effects of proposed projects. 
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lt is also evident that the medicinal plants sector spans a number of different agencies and organiza- 
tions. Whether or not their efforts can be effectively coordinated remains to be seen. They include: 
The Government of India and relevant State Governments, including the Ministries of Agricul- 
ture, Environment and Forests, and Health; 
The Private Traditional Medicine Sector, including companies active in each of the Indian Sys- 
tems of Medicine and Homeopathy; 
The Public Sector Research Institutions and Universities, including those focusing both on agri- 
cultural as well as medical research; 
Relevant Non-Governmental Organizations, which are locally involved in activities related to the 
medicinal plants sector, and which serve as representatives of the communities of collectors and 
users of plants and plant-derived drugs; and 
International networks in which India is represented, and international organizations concerned 
with the broader aspects of biodiversity. 
In terms of sustainable development, there are four obvious targets, most of which are recognized by the 
government and by donors: 
Focus on Women, Tribal Communities, and the Rural and Urban Poor who together 
constitute the largest group, both in terms of the people involved in the harvesting and collection 
of medicinal plants, as well as the users of folk and classical traditional medicines; 
Focus on Environmental and Biodiversity Conservation, especially forests, as these 
continue to be the primary habitat for medicinal plants, and linkages with incentives related to the 
sustainable management and rehabilitation of degraded lands; 
International Trade. India has a comparative advantage in the market and can generate a 
stronger presence globally; and 
Public Health Improvement, with a wider and higher-quality range of naturally-derived prod- 
ucts being made available in the market, which are accessible to the poor as well as the rich. 
71 Recommended 
hiterventions 
With regard to interventions for the medicinal plants sector, there are three key inter-related areas which 
need to be addressed in light of the following considerations: longer-term actions, existing information gaps 
and policy considerations. 
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Area 1: Sustaining the Resource Base 
Immediate Actions 
A. Ex-situ conservation 
Several medicinal plants are already threatened, rare, or endangered. In addition, the precautionary 
principle' applies to those whose status is currently unknown and to segments of genepools. There is an 
immediate need to consolidate and officially link the existing herbal gardens and genebanks, as well as 
reference specimens in herbaria, to ensure that the 540 species of highest importance in the major classical 
systems, as well as those supplied to the international market, are protected in ex-situ reserves. This re- 
quires strategic planning since the range of germplasm obtained for each species must be representative. 
Plant collections need to evolve from being species reference collections to being genetic resources collec- 
tions. 
Longer-Term Action 
A. Promoting Cultivation and Selection of Superior Genotypes 
The low number of medicinal plants currently being cultivated should be increased, in order to meet the 
demands of industry for continuous and uniform material supplies, and to take some of the pressure off 
medicinal plants originating from natural ecosystems. The selection of plants for cultivation must be market- 
driven: as has been shown, the species currently under study are largely for export, and there is a need to 
focus on others needed domestically by Indian industries. 
At present, commercial varieties have been developed for about 16 species, most of which are culti- 
vated for export. Much more needs to be done to select superior genotypes of many more species. 
To achieve this initiative, it will be necessary to make extensive use of the network of nurseries and 
gardens in the country, in order to establish high quality plant supply systems. Greater dissemination of 
information to farmers, regarding these holdings is also necessary, and should involve the agricultural exten- 
sion organizations since these serve as a primary interface with farmers in the country. 
B. Promoting Responsible, Sustainable Wild-Harvesting 
Wild-harvesting practices are presently highly unsustainable and are likely to remain so. The lack of 
sufficient information and of relevant scientific procedures are important contributing factors to this situation, 
as is the absence of any land rights regulations, which provide local communities with access to and some 
degree of control over their resources. There is thus a need to provide solutions to these constraints, as well 
as guidelines and incentives for sustainable wild-harvesting. Unfortunately little work has been done in this 
area. Additionally, an examination of the networks of traders and volume of illegal trade suggests that the 
provision of socio-economic and market information may be the primary need. 
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C. In-situ conservation 
It will be necessary, based on an understanding of where medicinal plants are currently distributed, to 
develop novel programs for their in-sftu conservation and to designate specific genetic reserves. This inter- 
vention also applies to timber species as well as wild relatives of crops, and current government activities 
relating to protected areas may need to be modified in order to accommodate these species. The implemen- 
tation of Joint Forest Management schemes in these areas would be the logical approach to use, given the 
viability of medicinal plants for generating income as well as rehabilitating degraded lands. Due to their 
position as the major stewards of the resource base, women and tribal groups, especially, should be given 
some control over these lands. 
The approach adopted should encompass existing initiatives introduced by organization such as the 
Bangalore-based NGO, FRLHT, and its Medicinal Plant Conservation Areas Network. In addition, these in- 
situ conservation areas should be made to serve several functions, such as the provision of education and 
awareness- building, as well as training for sustainable harvesting methods. 
Information Gaps 
A. Distribution of Resources 
It will be critical to understand the actual distribution of the resources and to research their genetic 
diversity for policy and strategies formulation. This is a long-term process and a research framework needs to 
be developed to this end. 
B. Market Status of Certain Crops 
The other major information gap continues to relate to the lack of socio-economic information. It will be 
vital for cultivation efforts to identify, in collaboration with local industry, which medicinal plants are in greatest 
demand and are suitable for cultivation. This first step is essential and research will be needed to gauge the 
demand and profit-making potential of plants. In addition, prior to the introduction of the plants into cultivation, 
research will be necessary to clarify how market linkages can be most effectively, established in order to 
assess the gains to the producers. This is a significant gap which has to be addressed. 
C. Agro-Technical Packages for ntercropping and 
Farm Forestry 
For the identified plants of major market significance, agro-technical packages need to be developed for 
cultivation and propagation. In general, most medicinal plants when cultivated have been sole crops in 
restricted ecological regions. Farm forestry and intercropping systems will have to be devised, as has already 
been done for the major species cultivated for export, and there will have to be shift to a more farm-centered 
approach which recognizes, that in most cases, medicinal plants will only constitute one of many crop types 
adopted by farmers. 
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Policy Considerations 
A. Domestic policy 
There are two areas in which policy should to be reconsidered: firstly, in terms of delegating control of 
resources to local people, through JFM and related initiatives, and secondly, in terms of its implementation 
and enforceability. 
As regards this second area, policies frequently lack evaluation and follow up. Thus, for example, the 
Forest Policy of 1988, proclaiming tribal rights to forests, is yet to receive official sanctioning through the 
passing of Acts, while the fact that many of the supposedly regulated plant species have not been identified 
in manuals, means that their collection cannot be determined and therefore stopped. Also, forest policy which 
requires that forest lands should not be used for agricultural activities of any kind may be usefully amended in 
some cases to allow for medicinal plants cultivation, within farm and agroforestry systems. 
B. Accordance with Conventions 
India is a signatory to a number of Conventions related to the medical plants resource base. CITES and 
CBD are obvious examples. The latter has many policy implications concerning the medicinal plants sector. 
These should be resolved in such a way that India dops not become monopolistic and recognizes its interde- 
pendence with other countries. This evidently gives the strong representation of introduced materials amongst 
the raw plant materials exported, and India will continue to benefit from advances made in medicinal plant 
research in other countries. 
Area 2: Measures for Achieving A Thriving Folk 
Medical Tradition 
Immediate Actions 
A. Establishment of Village Level Germplasm Collections 
Apart from the commercially important plants and those important in the classical traditions, there is 
also a need to conserve important plants used in folk and tribal medical practices for the benefit of those 
people. To this end, the development of village germplasm collections is a useful intervention which should be 
undertaken. 
Longer-Term Action 
Overall, the major orientation of a program in this area should be focused first and foremost on the health 
care needs of the communities which practise folk and tribal medicine. There are two activities which can be 
undertaken to achieve these results. 
A. Village "Self-Health" Program 
Following the recommendations of the South Asia Conference on Tribal and Folk Plant-Based Medicines, 
a network of pilot projects should be developed, focusing on the generation of sustainable and self-sustaining 
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tribal medicine. These projects would involve communities joining hands with development specialists to 
assess the current status of their plant-based remedies, as well as of the resource base of the plants 
themselves. Based upon these findings, more comprehensive projects could be planned and implemented to 
ensure that their health care becomes sustainable (in terms of the natural resource base) and self-sustaining 
(through fair marketing and cultivation where suitable). The development of a network of such pilot projects 
could thus serve as a foundation for further actions and ongoing work, as well as solve the problem of the 
current isolation experienced by projects of this nature. 
B. Development of a Tribal Materia Medica 
This could build upon the existing databases, with the addition of detailed information regarding meth- 
ods of use and preparation. It should record the innovations of local communities, thereby ensuring that these 
are recognized, and should be linked to awareness building and the promotion of tribal and folk medicine. 
Filling Information Gaps 
A. Social and Economic Studies 
Little information exists regarding the social and economic context of folk medicinal practices. There is 
therefore a need to undertake studies which document the full range of situations at the village level, in order 
to understand how interventions can be targeted to assist in developing sustainable and self-sustaining medicinal 
plants practices. This research can be undertaken by the communities in collaboration with researchers. 
B. Toxicology Studies and Standard Preparations 
It is important to ensure that the plants used as medicines by the rural people are not also toxic in other 
ways. This is therefore one area in which modern technology can be of great service. In addition, standard 
preparations need to be developed to improve the quality, efficacy and effectiveness of the traditional drugs. 
Policy Considerations 
Current policies have neglected the folk traditional sector, which should be included in legislation and 
policy development especially in relation to primary health care centres and folk practitioners. 
Policies regulating safety and efficacy need to be evolved based on a recognition of the uniqueness of 
tribal and folk medicine, and these should be linked to intellectual property rights which ensure that communi- 
ties benefit from the use made of their technologies. 
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Area 3: Measures for Achieving an Equitable 
Marketing System and a Thriving 
Medicinal Plants Industry 
Immediate Actions 
A. Setting Up a National Level Authority 
Following the lead of the private sector, the government or a related body could set up a national board 
specifically for the purpose of sustainably developing the sector, and addressing all the concerns entailed. 
Such a body would comprise of representatives from the various stakeholders, as well as resource persons 
with significant expertise in economics and soclo-ecoriomics. 
B. Making Cooperatives More Responsive and Representative 
A second need relates to cooperatives. The fundamental thinking behind cooperatives has in most 
cases been flawed, and experience has shown that such organizations cannot replace the middleman, who 
processes valuable information as well as the scope to provide credit and advances. Although the scope of 
cooperatives has usually been limited to simply being a group of producers working together to create their 
own market linkages, it would be useful to build these up into more comprehensive organizations, with skills 
in collecting, cultivation and semi-processing where appropriate. 
Longer-Term Action 
A. Formalizing and Organizing the Market 
A key task is to bring a greater degree of formality and organization to a market which has been shown 
to be inefficient, imperfect, informal, and opportunistic. If a greater degree of formality cannot be achieved in 
the market, it is unlikely that other efforts will be of significant use in preserving traditional medicine and its 
resource base. 
The call for formality is not, however, a call for state intervention per Se; nor is it a call for a Marketing 
Board, as some have suggested. Rather, the transformation of the market should be accomplished through a 
number of coordinated small steps taken by different actors, who together agree upon an agenda specifying 
their roles through the coalition body proposed above. This will require a type of social contract' between 
government, the private sector, research institutions, and NGOs representing the local people. Rather than 
enacting new laws or legislation, this group would rather formulate novel projects and programs which could be 
undertaken together, and for which each member would provide funding as well as implementation and 
oversight functions. A number of suggested projects which would be of use include: 
B. Dissemination of Market Information and Adding Value at the 
Local Level. 
Both of these need longer-term planning and action since the major Indian markets currently require 
virtually no processing before the plants reach wholesalers. Goals would include devolution of resource 
management authority and the establishment of reliable markets with regular returns for inputs. 
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Filling Information Gaps 
A. Making Sense of the Domestic Market 
Most essential to the process of developing the industry and the sector will be the gathering and dis- 
semination of information. Currently little is known about the market, especially of the informal sector. This 
information will be essential to the coordinated planning required for the sector in order to deal effectively with 
all stakeholders. Donor agencies and the government will need to work with the private and public sector 
research communities to finance such studies which will follow plants through the market, documenting mar- 
gins, numbers of people involved, and the like. Such studies will also serve to highlight the major players, the 
degree of concentration in the market, and the opportunities for new interventions. 
B. Finding Opportunities in the International Market 
However, a priority Intervention must be to enable companies in India to compete effectively in the 
global market and to exploit the comparative advantage of India in terms of its medico-cultural expertise and 
biological diversity. Research is needed which will identify opportunities in the global market in which Indian 
ventures would be uniquely suited to participate and perform strongly. 
Policy Considerations 
A. Support for the Traditional Industry 
Given that the highly-subsidized allopathic industry could become outmoded as a result of global com- 
petition, the government needs to consider whether or not some of the support extended to allopathic compa- 
nies might be transferred to its own traditional industry as a supplier of finished drugs. 
B. Regulations on Domestic and International Trade 
Trade regulations are currently unenforced for the most part, at every level of the marketing chain. In 
some cases, in fact, it is necessary for the government to reconsider whether the systems of permits and 
licences required for forest use can be simplified, and made more friendly to the users of the resource. 
Current policies are cumbersome and not well integrated, and also uniformly eliminate certain possibilities and 
opportunities. 
For international trade purposes, the major requirement is for better enforcement of existing policies, 
such as the CITES Convention and related export regulations. Currently, the lack of identification methods for 
some plants, and of training for customs officials, result in a very large amount of trade being impossible to 





AICRPE All India Coordinated Research Project on Ethnobotany 
AICRPMAP All India Coordinated Research Project on Medicinal and Aromatic Plants 
ANMAP Asian Network for Medicinal and Aromatic Plants 
APEDA Agricultural and Processed Food Export Development Authority 
APINMAP Asia-Pacific Information Network for Medicinal and Aromatic Plants 
BCN Biodiversity Conservation Network 
BGC Botanic Gardens Conservation International 
CBD Convention on Biological Diversity 
CCRAS Central Council for Research in Ayurveda and Siddha 
CCRH Central Council for Research in Homeopathy 
CCRUM Central Council for Research in Unani Medicine 
CDRI Central Drug Research Institute 
CIMAP Central Institute for Medicinal and Aromatic Plants 
COMFORPTS Centre for Minor Forest Products 
CROMAP Current Research on Medicinal and Aromatic Plants 
CSIR Centre for Scientific and Industrial Research 
CITES Convention on International Trade in Endangered Species 
DBT Department of Biotechnology 
DGCIS Directorate General of Commercial Intelligence and Statistics 
DST Department of Science and Technology 
FAQ Food and Agriculture Organization 
FRLHT Foundation for the Revitalization of Local Health Traditions 
GATT General Agreement on Trade and Tariffs 
81 
A Review of the Medicinal Plants Sector in India 
GSCS Girijan Service Cooperative Society 
G-1 5 GEBMAP Group of 15 Genebanks for Medicinal and Aromatic Plants 
GIFTS of Health Global Initiative for Traditional Systems of Health 
GOI Government of India 
ICAR Indian Council for Agricultural Research 
ICFRE Indian Council for Forestry Research and Education 
ICMR Indian Council for Medical Research 
ICRISAT International Centre for Research in the Semi-Arid Tropics 
IDAC International Development Research Centre 
INMEDP LAN Indian Medicinal Plants Database 
IMPN IDRC Medicinal Plants Network 
INMEDGREN Indian Medicinal Genetic Resources Network 
ISM Indian Systems of Medicine 
ITC-HS International Trade Classification-Harmonized System 
IUCN The World Conservation Union 
LAMPS Large Area Multi-Purpose Cooperative Societies 
MAPA Medicinal and Aromatic Plants Abstracts 
MAPPA Medicinal and Aromatic Plants Program in Asia 
MFP Minor Forest Produce 
MPCA Medicinal Plants Conservation Areas 
MPSG Medicinal Plants Specialist Group 
NABARD National Bank for Agriculture and Rural Development 
NBPGR National Bureau for Plant Genetic Resources 
NGO Non-Governmental Organization 
NTFP Non-limber Forest Product(s) 
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NWFP Non-Wood Forest Product(s) 
OECD Organization for Economic Cooperation and Development 
PA Protected Area 
PID Public Information Directorate 
SAARC South Asian Association for Regional Cooperation 
SC/ST Scheduled Caste/Scheduled Tribe 
SITC Standard International Trade Classification 
TFRI Tropical Forest Research Institute 
TRIFED Tribal Federation 
TRIPS Trade-Related Intellectual Property 
UNCED United Nations Conference on Environment and Development 
WCMC World Conservation Monitoring Centre 
WHO World Health Organization 
WWF World Wide Fund for Nature 
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A Red Data List of 
South Indian Medicinal Plants* 
Species Name Status 
Acorus ca/amus VU/R 
Adenia honda/a VU/R 
Adhatoda beddome! CR 
Aeg/e marme/os VU/R 
Aerva wiqhtll EX 
Amorphophallus paeonifollus V U/R 
Ampelocissus araneosa VU 
Ampe/oc/ssus md/ca EN/R 
Andrographisparilcu/ata LR 
Aristolochia bra cteo/ata L R 
Ar/sto/ochia tagala VU/R 
Artem/s/a ni/ag/rica LR 
Asparagus rattler! EX 
Balan/tes aegyptica LR 
Buchanan/a /anzan LR 
Qayratia pedata var. glabra CR 
Cleome burmann/ D D 
Commiphora mukul VU/R 
Cosc/n/um fenestratum CR 
Cycas c/rc/na/is C R!R 
Cyclea f/ssicalyx EN 
Drosera ind/ca L R 
Drosera peltata VU/R 
Elaeagnus con ferta L R 
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Embe//a ribes LR 
Garcii/a indica VU 
Gamin/a inorella VU/A 
Gardenia gummifera LR 
Glor/osa superba LR 
Glycosmis macrocarpa LR 
Hedych/um coronar/um LR 
He//otrop/um kera/ense EN 
Ho/ostemma annu/are V U/R 
Hydnocarpus macrocarpa VU 
Janak/a araya/patra CR 
Kaempfer/a galanga C RIR 
King/odendronp/nnatum EN 
Lamprac/iaen/um in/crocepha/um EN 
Madhuca diplostemon EN 
Madhuca insiinis EX 
Michelila champaca VU 
Moringa concanens/s VU 
Myr/st/ca ma/abarica EN 
Nervi/la aragoana EN 
Nllg/r/ant/ius cillatus EN 
Ochceinauc/ea miss/on/s VU 
Opercu/ina turpethum LR 
Oroxyluin /nd/cum VU/A 
Paph/apedi//um drury/ CR 




Piper niqrum VU 
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Plectranthus vettivero/des EW 
Pterocarpus santal/nus EN 
Pseudarthr/a V/s cida LR 
Puereria tube rosa L R 
Rauwo/u/a serpent/na E N/R 
Saraca asoca E NIR 
Schrebera swe/tenodes VU/R 
Symp/ocos coch/nch/ns/s subsp/aur/na VU 
Symplocos racemosa LR 
Syzyg/um tra vancor/cum CR 
T/nospora s/nens/s VU /R 
Trag/a b/color V U 
Trichopus zey/an/cus subsp. travencor/cus VU 
Ut/er/a sal/c/to//a CR 
Vateria in dica L R 
Vater/a macrocarpa CR 
Vernon/a anthe/mintica L R 
Woodford/a frut/cosa L R 
CR = Critically Endangered; EN = Endangered; EX = Extinct; VU = Vulnerable; LR Low Risk; 
DD = Data Deficient; EW = Extinct in Wild; IA = Regional Assessment 
* Based on FRLHT Threat Assessment using IUCN guidelines, 1994-95. 
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Appendix 2 
Some of the Major Commercial Cultivation Areas 
of Medicinal and Aromatic Plants 
No. Crop Area (ha) 
1. Psyllium (Plantago) 
2. Senna (Cass/a) 
3. Opium poppy 




7. Khasi kateri 
(So/anum v/arum) 
8. Japanese Mint 
9. Basil 
10. Aniseed 
11. Lemon grass 
12. Palmarosa grass 





States where grown 
North Gujarat and Northwest Rajasthan 
Coastal districts of Tamil Nadu 
Madhya Pradesh, Rajasthan and Uttar Pradesh 
Central Parts of Madhya Pradesh 
Darjeeling district (West Bengal) 
Ooticamund district (Tamil Nadu) 
Northern West Bengal 
Maharashtra 
Uttar Pradesh and Punjab 
Uttar Pradesh 
Punjab and Western Uttar Pradesh 
Kerala 
Uttar Pradesh, Karnataka 
Assam, Meghalaya, Andhra Pradesh 
Kerala, Karnataka, Tamil Nadu 
Tamil Nadu, Karnataka 
Tamil Nadu, Karnataka 
Uttar Pradesh 
Notes 1. For most of these species intercropping is practised. 
2. To this list should be added Rauwo/f/a serpent/na, indigenous; Artem/sia annua, introduced; and 
Catharanthus roseus, introduced (Authors). Of the species listed in the table, 5 of the 17 are 
indigenous to India, 2/17 are Mediterranean, 1/17 European, 1/17 S.W. Asian, 1/17 S.E. Asian, 
1/17 N. American, 1/17 S. American, 1/17 E. African, 1/17 E. Asian, 1/17 S. African and 2/17 




















Development of Standardized Agrotechnology 
Underway at Indian Research Centres 
No. Centre Plants Under Investigation 
1. National Bureau of Plant Genetic Papa ver somniferum, Catharanthusroseus, 
Resources, New Delhi Hyoscyamus nigei Ocimum basi//cum, 
Vet/veria zizan/odes 
2. Indian Institute of Horticultural Research, Catharanthusroseus, Solanumsp., 
Bangalore Pogostemonpatchou//, Vet/vet/a 
zizan/odes,Jasn7/num sp. 
3. Dr Y. S. Parmar University Dig/ta/is lantana, So/anum /ac/n/atum, 
of Horticulture & Forestry, Solan, H. P. Swert/a chirata, Va/er/ana wa/lichil 
4. J. N. Krishi Vishwa Vidyalaya, Papaversomniferum, Withania somnifera, 
Agriculture College, I ndore, and G/ycyrrhlzag/abra,Hyoscyamus niger 
Research Station, Mandsaur, M. P. Vet/vet/a zizaniodes 
5. Rajasthan College of Agriculture, Papa vet somniferum, Chiorophyl/um 
Udaipur tuberosum 
6. A. N. D. University of Agriculture Papa vet somn/ferum, Hyoscyamus niger 
and Technology, Faizabad, U. P. 
7. Gujarat Agriculture University, Plantago ovata, G/ycyrrhizag/abra, Cassia 
Anand Campus, Anand, angust/fo//a, Comm4'horamuku/, 
Gujarat Chiorophyllum tuberosum 
8. Kerala Agriculture University, Trichur Pogostemonpatchou// 
9. Harayana Agriculture University, P/antago ovata, Glycyrrh/za glabra, 
Hissar, Harayana Menthaspp. 
10. Punjab Agriculture University, Ludhiana Menthaspp. 
11. National Botanical Research Institute, Papaversomniferum 
Lucknow 
12. Tamil Nadu Agriculture University, Jasm/nuni sp. 
Coimbatore 
13. University of Agriculture Sciences, Glor/osa superba, Artem/s/a sp. 
14. Central Institute of Medicinal Dubo/seamyoporo/des, Dioscorea spp. 
and Aromatic Plants, Lucknow 
15. Punjabrao Krishi Vidyapeet, Rauwo/f/a serpent/na, So/anum sp., Oc/muni 
Akola, Maharashra kiI/mandschar/ciim, Catharanthus roseus 
* Data from Amruth (1994) 
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Species Under Study by CIMAP for 
Tissue Culture Propagation 
Name of plant 
Acon/tum heterophylluni 
Chrysanthamum c/nerar/aefolium (Pyrethrum) 
Gymbopogon flexuosus (Lemon grass) 




Dioscorea deltoidea (Yam) 
Dubo/s/a myoporoides' (Corkwood) 
Mentha arvensis (Mint) 
Nardostachysjatamans/ (Jatamansi) 
Panax quinquefo//a (Amer/can ginseng,) 
P/crorrhiza kurrooa 
Pogostemon cab//n Patchou/i,) 
Rauwo/f/a serpent/na ('Rauwo/fia,) 
Rauwo/fla vom/tor/a 
Rheum emod/ (Rhubarb) 
Va/er/ana wa//ich// (Va/er/an) 
Vetiveria zizanioldes (Vetiver) 
* Introductions 
** 
Originally from SE Asia Annotations by the Authors 
Mid to high Himalayas 
Source : Amruth (1994), 
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Appendix 5 
Herbal Gardens In India 
No. Address Size of No. of Objectives Problem 
Gardens Species Areas 
1 Regional Research Laboratory 100 47 Research Shortage 
Jorhat,Assam 785 006 of funds 
2 Gujarat AgricultureUniversity 0.65 150 Research Shortage of 
Anand Campus, Anand funds, lack 
Gujarat 388 110 of technical 
expertise 
3 Directorate of Indian Medicine 37 200 Education 
Dhanavantari Vana, GCIM Campus 
Near Bangalore University 
Bangalore, Karnataka 560 009 
4 Forest Research Centre 25 300 Training, Shortage 
Terakanahalli, Sirai Taluka Education of funds 
Uttara Kannada District, Karnataka 
5 Indian Institute of Horticultural 1 65 Research Shortage 
Research, Hessarghatta Lake of funds, 
Bangalore, Karnataka 560 080 water 
shortage 
6 Taralabalu Rural Development 1 16 Training, Water 
Foundation, Sirigere, Education shortage 
ChitradurgaTaluka, Karnataka 577 541 
7 University of Agricultural Sciences 5 38 Research, Shortage 
Division of Horticulture Education of funds 
G K V K Campus, Bangalore 
Karnataka 560 065 
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8 Arya Vidya Sala 8 600 Education Water 
Kottakal, Malappuram District shortage 
Kerala 676 503 
Contact Person 
Mrs Indira Balacharidran 
9 AVREFAHerbalGarden 15 300 Education Shortage 
AVP Factory Complex, Kanjikode of funds 
District Paighat 
Kerala 678 621 
10 Chittayil Memorial Trust 2 300 Education, 
Olivayappu, Allapuzha District Research, 
Kerala 688 560 Training 
11 Kerala Forest Research Institute 2 250 Education, Shortage 
Peechi, District Trichur Research, of funds, 
Kerala Training inadequate 
land area 
12 Tropical Botanical Garden 300 750 Education, Shortage 
& Research Institute Research, of funds 
Palode P 0, Karimancode Training 
District Trivandrum, Kerala 695 562 
13 Regional Research Centre Ayurveda 45 250 Education, 
Gwaliar Road, Jhansi Research 
Madhya Pradesh 284 003 
14 State Forest Research 15 45 Education, 
Polipather, Jabalpur Research 
Madhya Pradesh 284 006 
15 Academy of Development Science 22 450 Shortage 
Kashele, Karjat, District Raigarh of funds, 
Maharashtra 410201 water 
16 JaneevaMandal 0.5 120 Shortage 
Kotri Road, Nandurbar of funds 
Maharashtra 425412 
17 Jawaharlal Nehru Ayurvedic 19.5 145 Education, 
Medicinal Plants Garden Research 
and Herbarium 
Kothrud, Pune, 
Maharashtra 411 029 
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18 Punjabrao Krishi Vidyapeeth - 100 Research, 
Nagarjun Medicinal Plants Garden Education, 
Krishi Nagar P 0 , Akola Training 
Maharashtra 444 104 
19 NBPGRBaseCentre 0.02 15 Research 
CRRI Campus, Cuttak, 
Orissa 753 006 
20 Regional Research Centre 142 45 Education, 
(Ayurveda)Guddal Herbal Farm, Research 
P 0 Mangliawas 
Ajmer District, Rajasthan 
21 Centre for Rural Health 2 60 Education, Shortage of 
& Social Education Training funds, Lack 
A-li, Ashok Nagar, Tiruputtur of technical 
N A A District, Tamil Nadu 635 601 expertise 
22 Forest Research Institute 12.5 45 Research, 
MPF Division, P 0 New Forest Education 
Dehra Dun, Uttar Pradesh 248 006 
FRI Dehra Dun Garden 
23 National Botanical Research Institute 6 220 Research, 
Rana Pratap Marg, Lucknow Education 
Uttar Pradesh 226 001 
24 N D University of Agriculture 0.65 27 Research, Shortage of 
& Technology, Education funds, infertile 
Narendra Nagar (Kumargunj) soil, inadequate 
Faizabad, Uttar Pradesh 224 229 land area 
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Important Species in the Herbal Garden, 
Tropical Forest Research Institute, Jabalpur 
S.No. Botanical Names Local Names 
1. Abe/moschus moschatus Mushkadana 
2. Abroma augusta Ulatkambal 
3. Abrusprecatorius Ghungchi (White seeded) 
4. Acorusca/amus Bach 
5. Aerva/anata Gorukh ganja 
6. A/Hum porrum Van lasun 
7. Ar/sto/ochia bra cteoata Kiramar 
8. Argyre/aspeciosa Kapurbashi 
9. Artemisiaspec/osa sp.Vidhara 
10. Bar/er/a pr/onftis Brahmi 
11. Bornbax ceiba Katsareya 
12. Butea monosperrna Semal 
13. Caesa/p/n/a crista Palas( White flowered) 
14. Caesa/p/nia crista Palas (Yellow flowered) 
15. Celastrus pan/c ulatus Gataran 
16. Cente/la as/at/ca Malkangani 
17. Ch/orophytum tuberosum Bramhi 
18. Cissus quadrangu/aris Safed mush 
19. C/erodendrurn siohonathus Hadjod 
20. CI/tor/aternatea Bharangi 
21. Coch/ospermum reIii/osum Aparajita (White flowered) 
22. Convolvulusplur/caulis Gongal 
23. Curcumaamada Shankhapushpi 
24. Curcumacaesia Amahaldi 
25. Dioscoreadaemona Kalihaldi 
26. Eryngiumfoet/dum Baichandi 
27. Eu/ophianuda JangahiDhania 
28. G/oriosasuperba Bilaikand 
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29. Kaempferiaga/anga Kalihari 
30. Luffa acutangu/a 
31. Ma/axis rheed/ Kadu torai 
32. Nerv/I/apra/n/ana 
33. Oroxy/umind/cum Shyonak 
34. Peucedanum sp. Balraj 
35. Plumbagorosea Laichitrak 
36. Pzey/anica Chitrak 
37. Pogori,' car/nata (NervllI carinata,) 
38. Premnaherbacea Bajragantt 
39. P serratifo/la Arni 
40. Rauwo/f/a serpent/na Sarpagandha 
41. Stereospermum suaveo/ens Patola 
42. Tha//ctrumfo//o/osuni Piyaranga 
43. Tinospora cord/fo//a Giloy 
44. Thbu/us terrestris Gokhru, chhota 
45. Ty/ophora/nd/ca Antamool 
46. Urg/neaind/ca Jangalipyaj 
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BAT Hills Mysore 
Talacauvery Madikeri 
Savandurga Bangalore 
















Silent Valley Palakkad 
Wyanadu Wyanadu 
Source FRLHT (1995) 
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Some of the Most Important Medicinal 
Plants Used by Local Tribes 
No. Species Local Name Habit Uses 
1. Abrusprecatorius Rati Gunubi Perennial Root used for abortion, leaves 
climber used for liquorice, Cough 
2. Abut/Ion /nd/cum Kanghi Shrub Root used in fever, Leaves 
demulcent, seed aphrodisiac 
and demulcent 
3. Acacicatec/iu Khair Tree Used as astringent 
4. Acanthaspermumhicpidum Bichiya Herb Fruit is used in scorpion bite 
5. Achyranthesaspera Latjira Herb Dropsy, skin eruptions & 
Apamarg leprosy. Stems used as 
toothbrush. 
6. Adhatoda vasica Adusa Shrub Leaves & roots, in asthma, 
bronchitis and fever 
7. Ad/aritum cap/ilus veneris Father Herb Leaves used in piles, root in 
dysentery 
8. Aeglemarmelos Bel Tree Used in chronic dysentery, 
stomach pain and fever 
9. Ageratumconyzoides Gangauon Herb Leaf juice styptic 
10. A/angiumsalv/foI/um Akola Tree Tonic in refricent 
11. Ailanthus exe/sa Maharuk Tree Bark used to stop bleeding and 
for skin disease 
12. Aloe vera Ghigwar Herb Juice of plant is used in piles, 
malaria, stomach ache 
13. A/ys/carpus hamosus Lipti Herb Root decoction is used in cough 
14. Androqraph/span/culata Chirata Herb Decoction of plant is used in 
dysentery, malaria 
15. An/some/es/nd/ca Bhandari Herb Leaf decoction used in cough 
16. Arisaema tortuosum Birbanka Herb Root juice used in diptheria 
17. Argyreiaspeciosa Kapat Climber Root used in rheumatism, 
nervous disorders, leaves used in 
skin disease 
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No. Species Local Name Habit Uses 
18. Asparagus racernosus Satawar Herb Root is used as diuretc and as 
tonic 
19. Aty/osia scarabaeoides Balar pati Herb Plant iuice used for diarrhea in 
cattle 
20. Azadirachtaindica Neem Tree Leaves applied to boils in 
eczema and ulcer 
21. Barleria striqosa Badimohel Shrub Root power used in whooping 
cough 
22. Bau/iin/a vah/ii Mahul Tree Seed used as tonic, root 
decoction used in fever 
23. Bauhinia var/egata Kachnar Tree Bark powder is a tonic 
24. Bidens pilosa Dhus Herb Used in urinary tract disease 
25. Begonia picta Khatti, patti Herb Root used in cholera, juice of 
leaves anthelmintic 
26. Blumenopsis flava Kakranda Shrub Root used in cholera, juice of 
leaves anthelmintic 
27. Boerha via diffusa Santh Punarnava Herb Leaves for snake bite 
and root for skin inflamation 
28, Borreria auric u//form/s Meelnaghant Herb Vapour is inhaled to kill tooth 
worms 
29. Borreriastricta Singwala Herb Juice of plant is used in scorpion 
bite 
30. Buchanan/a /anzan Achar Tree Leaves, roots, fruits used in skin 
disease 
31. Buteasuperba Palas Bel Tree Bark, flowers, leaves, seeds and 
gum used in pain, swelling and 
heat eruption of children 
32. Careyaarborea Kumbhi Tree Seeds used in pain, swelling and 
rheumatism 
33. Cassia fistula Amaltas Tree Bark, leaves, flowers and fruits 
used for fractures and disloca- 
tion of bones 
34. Cassia occidental/s Kasondi Shrub Leaves and seeds used for skin 
disease, root used for snake bite 
35. Cassia tora Chekoda Shrubs Leaves, seeds used for skin 
disease and in leprosy 




Whole plant used in 
skin disease, leprosy and blood 
purification 
Root used as tonic 
Leaf paste is applied on wounds 
Root used in snake bite 
Whole plant used for bone 
fracture and asthma 
Whole plant used in leprosy and 
blood disease 
Root decoction used in malaria 
Gum-used in cough, bark used 
as antipyretic 
Root is useful in epilepsy, leaves 
are applied to wounds 
Juice of shoot is used for 
nervous disease 
Rhizome used as tonic 
Root is used as purgative 
Used for asthma, jaundice, cuts, 
wounds 
Rhizome used as digestive 
Rhizomes used for digestion, 
skin disease 
Plant boiled in water is taken for 
pain in chest 
The plant contains an essential oil 
Plant juice used as a tonic 
Various parts used for head 
ache, malaria and asthma 
Seeds used as astringent, as 
tonic and in asthma 
Bark - used for wounds and 
menstrual trouble 
Root used as tonic and in 
asthma 
Leaf juice is used in diarrhea 
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37. Centella as/at/ca Brahmi Herb 
Manduk 
parmi 
38. Chlorophytum tube rosum Sated mush Herb 
39. Ch/oroxyIonsw/eteni Bhiriva Tree 
40. C/ssampe/os pare/ca Kudupad Climbing 
shrub 
41. Cissusquadrangula Horijori Climber 
42. Clematic trdoba Climber 
43. Clerodendrum/nd/cum Bhormal Shrub 
44. Coch/ospermum reIiiosum Galgal Tree 
45. Co/ebrookeaoppos/t/fol/a Bihinda Shrub 
46. Canscorad/ffusa Shankarphuhi Herb 
47. Costusspec/osus Keokand,Keu Herb 
48. Crota/ar/aa/b/da Ban methi Herb 
49. Curcu/igoorch/o/des Kahi musle Herb 
50. Curcumaangust/fol/a Janghi tikhur Herb 
51. Curcuma aromat/ca Jangahi haldi Herb 
52. Cuscuta ch/nens/s Amrbel Climber 
53. Cyathaoc!inepurp urea Komdu Herb 
54. Cymbopogonf!exuous Gheeghas Herb 
55. Datura mete! Dhatura Shrub 
56. Dendroca!amus str/ctus Bans Woody 
grass 
57. Dendrophthoefa!cata Banda Parasitic 
shrub 
58. Desmodiumganget/cum Sarivan Herb 
59. Desmod/umtr/florum Anti Herb 
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No. Species Local Name Habit Uses 
60. Di//eniapentagyna Kallu, Aggai Tree Fruit used as tonic and for 
abdominal pain 
61. Dioscoreabu/bifera Kand, Ratalu Climber Tuber is used for piles, dysentery, 
syphilis and applied to ulcers 
62. Dioscoreapentaphylla Baraki, Kanta-alu Climber Tuber is used for dispersing 
swelling and as tonic 
63. Diospyrosme/anoxy/on Tendu Tree Leaves used for eye, skin and 
blood diseases 
64. Elephantopusscaber Gophi, Gojiva Herb Root powder is used for pneu 
monia, wounds, and paralysis 
65. Eleusineindica Matnkuri Herb Plant is used as a tonic 
66. Emblica off/c/na//s Amla, Aonla Tree Fruits used for dysentery, bitter 
tonic and triphala medicine 
67. Emilia robusta Badidong Tree Bark of root used in toothache 
68. Emilia sonchifolia Hirankhun Herb Plant juice used in fever 
69. Eranthemurnpurpureum Guisham Herb Whole plant promotes growth of 
fetus in cattle 
70. Euphorbiahirta Dudhi Herb Juice used for dysentery 
71. Evolvu/us a/s/no/des Shankhuli Herb Whole plant used for vomiting, 
dysentery 
72. Exacumpet/olare Barocharayrla Herb Plant used as tonic 
73. F/cusbenghaleris/s Bargad, Bar Tree Bark used in diabetes 
74. Fleming/a bracteata Mukhanada Shrub Root powder is used as tonic 
75. Glor/osa superba Kalihari Herb Root-Anticlysenm, refiri ng, 
aphrodisiac 
76. Grew/a til/aefolia Chikti, Damon Tree Bark used in diabetes 
77. Gymnema sy/vestre Gudmar Woody Leaves used in diabetes 
Climber 
78. Hardw/ckiab/nata Anjan Tree Bark and leaves used in 
gonorrhoea disease 
79. Hellcteres/sora Marophali, Shrub Fruit used for pain, 
Marod phali dysentery, diarrhea, diabetes 
80. Hem/desmus indicus Anat mul Twiner Root used for gonorrhoea 
disease and as tonic 
81. Heteropogonconton'us Shurval Herb Root is stimulant and diuretic 
82. Hibiscus sabdariffa Laimbari Shrub Leaves used in diarrhea 
83. Hyptis suaveolens Dona, Shrub Seed oil is applied to 




Decoction of leaves and stem is 
used in fever 
Plant is used in febrile eruptions 
Seeds are purgative, juice of 
plant is used to dysentery 
Root and fruit given to women 
when urine is lightly coloured 
Infusion of leaves given in facial 
paralysis 
Leaf paste is applied in 
rheumatism 
Bark used in rheumatism, 
and malaria 
Flower ash applied to ringworm 
root rubbed on the breast when 
milk does not pass from nipples 
Herb Plant powder is applied to 
cure itchy infections of skin, root- 
powder given in muscular pain 
Flower used for colds and 
leaves for skin disease 
Flowers used as remedy for 
cough and cold 
Bark used in malaria, stomach 
ache 
Seeds used for tape worm 
Root given to cattle to kill worms 
Bark & root are used in fever 
and colds 
Seed used as aphrodisiac and 
for scorpion sting, 
root used in fevers 
Herb Shoot used in rheumatism, 
paralysis, Leaves used for 
seminal weakness 
Herb Plant juice given in jaundice 
& liver disease 







































92. Lep/dagathis trfr7eivia Ridhatti 
93. Leucas aspera 
94. Leucas cephalotes 
95. Litseapolyantha 
96. Ma/lotus phi/i,bpens/s 




















100. Oc/murngrat/ssimum Ram tulsi 
101. Olden/and/a corymbosa Dhadra 
102. Oxa/is corn/cu/ata Chotakhatua, 
Amrulsak 
A Review of the Medicinal Plants Sector in India 
No. Species Local Name Habit Uses 
103. Phoeni)' sy/vestr/s Chindi Tree Juice of stem used as cooling 
beverage 
104. Phy//anthus urinar!a Bhimli Herb Root juice used in jaundice 
105. Physa/is rn/ri/ma Tulati Pati Herb Juice used in earache 
106. Plectranthus Khatmer Herb Flowering twig used for many 
ternifollus medicinal purposes 
107. Polygonumbarbatum Herb Seed used to relieve colic pain 
108. Rung/a pect/nata Pindi Herb Leaves used to relieve pain and 
swelling 
109. Scoparia du/cis Muthipatti Herb Used for leprosy and diabetes 
110. Semecarpusanacardlum Bhilwa Tree Gum used in veneral disease 
111. Sidacord/folia Kungyi, Shrubs Root used in fever, 
Kharenti bark used in paralysis 
112. Sm//ax zey/anica Ramdaton Climber Root used in rheumatism and 
dropsy 
113. Smith/a conferta Herb Whole plant used as tonic to 
cure sterility 
114. So/anumindicum Bhatkutai, Herb Root used for muscular pain, 
Makoi cholera, dry cough 
115. Solanum niqrum Makoi Herb Leaves, fruits used in eye 
disease; Hair dye 
116. Sterculia urens Kulu, Gulu Tree Tender leaves, gum used to 
facilitate delivery and for skin 
eruptions 
117. Strobi/anthesaur/cu/ata Satputa Herb Roots used in coughs & colds 
118. Swleteniarnahagon! ____ Tree Bark used as astringent 
119. Syzyglum cumin! Jamun Tree Seed powder used for diabetes 
120. Tamarlndus lad/ca Imli, Amli Tree Fruits used as digestive 
121. Tephrosia purp urea Sarphunka Herb Leaf decoction is used in coughs 
and colds 
122. Terminal/a arjuna Kohua, Arjun Tree Juice is used in diarrhea 
123. Terminal/a bellerica Bahera Tree Fruits used for intestine trouble 
124. Terminal/a chebula Harra Tree Bark used as cardiac tonic, fruit 
used for gas 
125. Trichodesma Indicum Chota kulpha Herb Root used to reduce swelling of 




No. Species Local Name Habit Uses 
126. Thdaxprocumbens Baramasi Herb Leaves used in bleeding piles, 
peptic ulcer 
127. Trfijmfetta Chikti Shrub Bark used in diarrhea and 
rfiombo/dea dysentery 
128. 1./rena lobata Bhinda, Unga Shrub Root paste used externally for 
rheumatism 
129. Ventilago calycu/ata Raidhani, Herb Used for earache 
Kalibel 
130. Vernoniaroxburghi/ Sahdovi Herb Root given used in dropsy, seed 
used as anthelmintic 
131. Woodfordia frut/cosa Dawidhaura Shrub Flowers used for ulcers and 
Dhau rheumatism 
132. Xanthium strumarium Gokuru Herb Flowers used for coughs and 
colds and for toothache 





On Tribal and Folk Medicinal Plant Resources 
On 4-6 September 1996, under the auspices of the IDRC Medicinal Plants Network, and hosted by the 
Herbal Folklore Research Centre, Tirupati, a group of experts on tribal and indigenous culture and medicine, 
economic botany, ethnobotany, forest and agricultural resource management, forest and agricultural econom- 
ics, pharmacology, public health, and socio-economic development, from India, Sri Lanka, Nepal, and 
Bangladesh came together in the South Asia Conference on Tribal and Folk Medicinal Plant Resources. 
These experts came together to discuss the current status of plant-based tribal and folk medicine and to 
develop an action plan for the successful development of sustainable and self-sustaining tribal and folk 
medicine, in light of the recognition that: 
Tribal communities in South Asia represent the poorest of the poor in the developing world; 
The vast majority of people in these communities are dependent upon tribal, folk, and mostly plant- 
based medicines for meeting their primary health care needs; 
These systems of medicine play a significant role in the lives and culture of these peoples; and 
The production, processing, and utilization of plants for medicine offers a significant means of in- 
come generation for the people, as well as tremendous potential for increasing these socio-economic 
benefits for poverty alleviation. 
On the basis of their discussions, the delegates to the Conference identified six major areas for future 
actions, and developed a set of priority actions for each area agreed to in the following Declaration: 
1. Networking and Coordination 
a. Noting that a number of projects are underway throughout the region, and expertise in particular 
areas is quite high; and 
b. Recognizing that researchers remain largely isolated from one another, with frequent duplication of 
effort and lack of a strategic focus; 
The Conference is resolved that there is a need for more coordinated action and for development of 
partnershios between interested agencies. 
The Conference recommends that the following activities be undertaken: 
i. Development of a Tribal Medicine Network in the IMPN Secretariat; 
ii. Broad circulation of a newsletter focused on tribal and folk medicine in the region; 
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iii. Establishment of an electronic network of interested researchers; 
iv. Networking of industry interest groups for financial support of initiatives; and 
v. Development of an integrated, comprehensive, and accessible database,bringing together already- 
existing databases and filling in identified data gaps where existent. 
2. Broadening of Ethnobotanical Research 
a. Noting that while several studies have been carried out in the region, inventorying plants and their 
uses, little information regarding the collection, processing, administration, signficance of use, 
and cultural/socio-economic status of the users, has been collected; and 
b. Noting further that participation by the tribal communities themselves remains relatively low and 
partnerships are lacking which enrol them actively in the collection of information and decisions 
regarding development, and that this is a signficant gap in terms of developing projects which 
can have immediate and lasting impacts on peoples' lives and on primary health care among 
tribal communities; 
The Conference is resolved that: There is a c/ear need for more broad-based and comprehensive docu- 
mentation in ethnobotanical research. 
The Conference recommends that the following activities be undertaken: 
i. Development of a comprehensive data collection methodology, beyond enumeration of plants and 
their uses, to provide a complete picture of the tribal medicinal systems in the locations under study; 
ii. Publication of directories of medicine men and their expertise for consultation; and 
iii. Utilization of the comprehensive methodology to lay the groundwork needed for a Network of pilot 
projects/model village trials on self-sustaining and sustainable tribal medicine. 
3. Raising the Status of Tribal Medicine as an Effective 
Health Care Resource 
Aware that the tremendous financial and moral support given in favor of allopathy, and even more 
recently to classical traditional systems of medicine, has placed tribal and folk medicinal practices at a great 
disadvantage in terms of their profile and utility for local people; 
The Conference is resolved that there is a need to draw greater attention to these medicinal practices 
and to provide a scientific basis to increase pub/ic confidence and acceptance. 
The Conference recommends that the following activities be undertaken: 
i. Comprehensive research on actual use patterns at the local level to establish the importance and 
value of tribal and folk medicine in primary health care; 
ii. Comprehensive toxicity and pharmacological trials on those formulations reported from a number 
of locations in the region; and 
iii. Development of green health kits for rural and urban users; including a "green first aid kit" for 
emergency use. 
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The Conference further recommends that in all research and development ac- 
tivities undertaken, the following best practices be adhered to: 
iv. Clinical trials and case studies of effects of plant-based medicines be applied consistently and 
prior to promotion and marketing activities; and 
v. Standards and quality control methods be rigorously applied at each level of development for all 
drugs under development. 
4. Sustainable Management of the Resource Base 
Noting that research findings from throughout the region suggests that many of the plants used by 
tribal communities (as well as in other systems of medicine) are vulnerable, threatened, and rare; 
The Conference is resolved that action is needed to ensure that the resource 
base of medicinal plants continues to be available for the use of local tribal communi- 
ties first and foremost, as well as for the global community as a whole. 
The Conference recommends that the following activities be undertaken: 
i. Development of village-level gardens and community germplasm banks; 
ii. Research on tribal conservation and production traditions and sustenance; 
iii. Training of local groups in sustainable identification, collecting, and harvesting practices; 
iv. Development of planting supply information systems; 
v. Development of propagation and cultivation techniques for selected plants; and 
vi. Development, publication, and broad dissemination of a Tribal Materia Medica--highlighting plants 
used by different ethnic groups for different ailments. 
The Conference further recommends that in all research and development activities undertaken, the 
following best practices be adhered to: 
vii. Deposition of materials from all studies with national gene banks of medicinal and aromatic plants 
with appropriate agreements and protection; and 
viii. Use of standardized threat analyses to prioritize locally-needed plants in all areas under study. 
5. Equitable Sharing of Benefits and Increased Livelihood 
Security for the Poor 
a. Noting that current market structures place tribals at a distinct disadvantage in terms of economic 
benefits; 
b. Aware that this lack of support is resulting in the decline cf traditional knowledge as tribals faced 
with the need for gainful employment choose to learn other profitable income-producing skills; and 
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c. Also aware that the lack of strong economic benefits deriving from forests likewise increases 
continued overexploitation of these natural resources; 
The Conference is resolved that there is a need to bring about more equitable 
sharing of benefits resulting from the use of medicinal plants in healthcare. 
The Conference recommends that the following activities be undertaken: 
i. Development, at the village level, of cheap and low-cost post-harvest technology for value addition 
and increased income; 
ii. Study of the impacts of cultivation and domestication on the distribution of benefits; 
iii. Development of partnerships between tribes and users of the resources, village level gardens, and 
production and marketing cooperatives. 
The Conference further recommends that in all research and development activities undertaken, the 
following best practices be adhered to: 
iv. Communication and wide disemination of market and price information, as well as results of 
related research, to local-level producers and users; 
6. Supportive Policy Environment for Development of Tribal Medicine 
Recognizing that tribal medicine, subject to policies and regulations administered by a host of agen- 
cies, including those of Agriculture, Forestry, Health and Family Welfare, Tribal Welfare, etc., has found itself 
caught between a number of existing poTicies and consequently has not benefitted from a coherent and 
holistic approach to its development; 
The Conference is resolved that policies regarding land tenure and rights of access, intellectual property 
rights, conservation of resources, medical standards and quality controls, require assessment and direction 
from the perspective of ensuring sustainable and self-sustaining tribal medicinal practice. 
The Conference recommends that the following activities be undertaken: 
i. Production of a State-of-the-Art Review of Existing Policies affecting Tribal Medicine in the region; 
ii. Development of Curricula for education on tribal and folk medicine with formal recognition (diplomas, 
etc.); 
iii. Inclusion with appropriate cautions of tribal medicines in health care dispensaries, and employment 
of tribal medical doctors for consultations in primary health care centres; and 
iv. Granting of enforceable rights to tribals for self-use of forests within the context of Forest User 
Groups, Joint Forest Management, and similar programs in effect in particular countries of the 
region. 
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